P04637 (P53_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
Cellular tumor antigen p53

Alternative name(s):
Antigen NY-CO-13
Phosphoprotein p53
Tumor suppressor p53

Gene names

Name:	TP53
Synonyms:	P53

Organism

Homo sapiens (Human) [Reference proteome]

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

cellular organisms › Eukaryota › Opisthokonta › Metazoa › Eumetazoa › Bilateria › Deuterostomia › Chordata › Craniata › Vertebrata › Gnathostomata › Teleostomi › Euteleostomi › Sarcopterygii › Tetrapoda › Amniota › Mammalia › Theria › Eutheria › Euarchontoglires › Primates › Haplorrhini › Simiiformes › Catarrhini › Hominoidea › Hominidae › Homininae › Homo

Protein attributes

Sequence length	393 AA.
Sequence status	Complete.
Protein existence	Evidence at protein level

General annotation (Comments)

Function	Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; te function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Ref.34 Ref.42 Ref.61 Ref.66 Ref.69 Ref.90 Ref.92 Ref.102 Ref.105 Ref.117 Ref.120
Cofactor	Binds 1 zinc ion per subunit.
Subunit structure	Interacts with AXIN1. Probably part of a complex consisting of TP53, HIPK2 and AXIN1 By similarity. Binds DNA as a homotetramer. Interacts with histone acetyltransferases EP300 and methyltransferases HRMT1L2 and CARM1, and recruits them to promoters. In vitro, the interaction of TP53 with cancer-associated/HPV (E6) viral proteins leads to ubiquitination and degradation of TP53 giving a possible model for cell growth regulation. This complex formation requires an additional factor, E6-AP, which stably associates with TP53 in the presence of E6. Interacts (via C-terminus) with TAF1; when TAF1 is part of the TFIID complex. Interacts with ING4; this interaction may be indirect. Found in a complex with CABLES1 and TP73. Interacts with HIPK1, HIPK2, and TP53INP1. Interacts with WWOX. May interact with HCV core protein. Interacts with USP7 and SYVN1. Interacts with HSP90AB1. Interacts with CHD8; leading to recruit histone H1 and prevent transactivation activity By similarity. Interacts with ARMC10, BANP, CDKN2AIP, NUAK1, STK11/LKB1, UHRF2 and E4F1. Interacts with YWHAZ; the interaction enhances TP53 transcriptional activity. Phosphorylation of YWHAZ on 'Ser-58' inhibits this interaction. Interacts (via DNA-binding domain) with MAML1 (via N-terminus). Interacts with MKRN1. Interacts with PML (via C-terminus). Interacts with MDM2; leading to ubiquitination and proteasomal degradation of TP53. Directly interacts with FBXO42; leading to ubiquitination and degradation of TP53. Interacts (phosphorylated at Ser-15 by ATM) with the phosphatase PP2A-PPP2R5C holoenzyme; regulates stress-induced TP53-dependent inhibition of cell proliferation. Interacts with PPP2R2A. Interacts with AURKA, DAXX, BRD7 and TRIM24. Interacts (when monomethylated at Lys-382) with L3MBTL1. Isoform 1 interacts with isoform 2 and with isoform 4. Interacts with GRK5. Binds to the CAK complex (CDK7, cyclin H and MAT1) in response to DNA damage. Interacts with CDK5 in neurons. Interacts with AURKB, UHRF2 and NOC2L. Interacts (via N-terminus) with PTK2/FAK1; this promotes ubiquitination by MDM2. Interacts with PTK2B/PYK2; this promotes ubiquitination by MDM2. Interacts with PRKCG. Interacts with PPIF; the association implicates preferentially tetrameric TP53, is induced by oxidative stress and is impaired by cyclosporin A (CsA). Interacts with human cytomegalovirus/HHV-5 protein UL123. Interacts with SNAI1; the interaction induces SNAI1 degradation via MDM2-mediated ubiquitination and inhibits SNAI1-induced cell invasion. Interacts with KAT6A. Ref.8 Ref.34 Ref.38 Ref.42 Ref.43 Ref.54 Ref.55 Ref.56 Ref.57 Ref.58 Ref.59 Ref.61 Ref.62 Ref.64 Ref.65 Ref.66 Ref.67 Ref.71 Ref.72 Ref.73 Ref.74 Ref.75 Ref.77 Ref.79 Ref.80 Ref.82 Ref.85 Ref.86 Ref.87 Ref.90 Ref.91 Ref.97 Ref.98 Ref.100 Ref.101 Ref.102 Ref.107 Ref.108 Ref.111 Ref.112 Ref.114 Ref.116 Ref.117 Ref.119 Ref.120 Ref.122 Ref.130 Ref.131 Ref.132 Ref.133 Ref.134 Ref.144
Subcellular location	Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Nucleus. Nucleus › PML body. Endoplasmic reticulum. Mitochondrion matrix. Note: Interaction with BANP promotes nuclear localization. Recruited into PML bodies together with CHEK2. Translocates to mitochondria upon oxidative stress. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 1: Nucleus. Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Note: Predominantly nuclear but localizes to the cytoplasm when expressed with isoform 4. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 2: Nucleus. Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Note: Localized mainly in the nucleus with minor staining in the cytoplasm. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 3: Nucleus. Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Note: Localized in the nucleus in most cells but found in the cytoplasm in some cells. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 4: Nucleus. Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Note: Predominantly nuclear but translocates to the cytoplasm following cell stress. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 7: Nucleus. Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Note: Localized mainly in the nucleus with minor staining in the cytoplasm. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 8: Nucleus. Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120. Note: Localized in both nucleus and cytoplasm in most cells. In some cells, forms foci in the nucleus that are different from nucleoli. Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120 Isoform 9: Cytoplasm Ref.9 Ref.38 Ref.42 Ref.51 Ref.61 Ref.69 Ref.73 Ref.85 Ref.91 Ref.96 Ref.108 Ref.120.
Tissue specificity	Ubiquitous. Isoforms are expressed in a wide range of normal tissues but in a tissue-dependent manner. Isoform 2 is expressed in most normal tissues but is not detected in brain, lung, prostate, muscle, fetal brain, spinal cord and fetal liver. Isoform 3 is expressed in most normal tissues but is not detected in lung, spleen, testis, fetal brain, spinal cord and fetal liver. Isoform 7 is expressed in most normal tissues but is not detected in prostate, uterus, skeletal muscle and breast. Isoform 8 is detected only in colon, bone marrow, testis, fetal brain and intestine. Isoform 9 is expressed in most normal tissues but is not detected in brain, heart, lung, fetal liver, salivary gland, breast or intestine. Ref.9
Induction	Up-regulated in response to DNA damage. Isoform 2 is not induced in tumor cells in response to stress. Ref.9 Ref.38
Domain	The nuclear export signal acts as a transcriptional repression domain. The TADI and TADII motifs (residues 17 to 25 and 48 to 56) correspond both to 9aaTAD motifs which are transactivation domains present in a large number of yeast and animal transcription factors. Ref.48 Ref.89
Post-translational modification	Acetylated. Acetylation of Lys-382 by CREBBP enhances transcriptional activity. Deacetylation of Lys-382 by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence. Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylated by HIPK1 By similarity. Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter. Phosphorylated on Thr-18 by VRK1. Phosphorylated on Ser-20 by CHEK2 in response to DNA damage, which prevents ubiquitination by MDM2. Phosphorylated on Ser-20 by PLK3 in response to reactive oxygen species (ROS), promoting p53/TP53-mediated apoptosis. Phosphorylated on Thr-55 by TAF1, which promotes MDM2-mediated degradation. Phosphorylated on Ser-33 by CDK7 in a CAK complex in response to DNA damage. Phosphorylated on Ser-46 by HIPK2 upon UV irradiation. Phosphorylation on Ser-46 is required for acetylation by CREBBP. Phosphorylated on Ser-392 following UV but not gamma irradiation. Phosphorylated on Ser-15 upon ultraviolet irradiation; which is enhanced by interaction with BANP. Phosphorylated by NUAK1 at Ser-15 and Ser-392; was intially thought to be mediated by STK11/LKB1 but it was later shown that it is indirect and that STK11/LKB1-dependent phosphorylation is probably mediated by downstream NUAK1 (Ref.119). It is unclear whether AMP directly mediates phosphorylation at Ser-15. Phosphorylated on Thr-18 by isoform 1 and isoform 2 of VRK2. Phosphorylation on Thr-18 by isoform 2 of VRK2 results in a reduction in ubiquitination by MDM2 and an increase in acetylation by EP300. Stabilized by CDK5-mediated phosphorylation in response to genotoxic and oxidative stresses at Ser-15, Ser-33 and Ser-46, leading to accumulation of p53/TP53, particularly in the nucleus, thus inducing the transactivation of p53/TP53 target genes. Phosphorylated by DYRK2 at Ser-46 in response to genotoxic stress. Phosphorylated at Ser-315 and Ser-392 by CDK2 in response to DNA-damage. Ref.28 Ref.29 Ref.30 Ref.33 Ref.36 Ref.38 Ref.41 Ref.44 Ref.46 Ref.49 Ref.50 Ref.52 Ref.53 Ref.57 Ref.58 Ref.61 Ref.67 Ref.71 Ref.73 Ref.76 Ref.77 Ref.78 Ref.80 Ref.84 Ref.88 Ref.91 Ref.92 Ref.97 Ref.106 Ref.111 Ref.117 Ref.119 Dephosphorylated by PP2A-PPP2R5C holoenzyme at Thr-55. SV40 small T antigen inhibits the dephosphorylation by the AC form of PP2A. Ref.28 Ref.29 Ref.30 Ref.33 Ref.36 Ref.38 Ref.41 Ref.44 Ref.46 Ref.49 Ref.50 Ref.52 Ref.53 Ref.57 Ref.58 Ref.61 Ref.67 Ref.71 Ref.73 Ref.76 Ref.77 Ref.78 Ref.80 Ref.84 Ref.88 Ref.91 Ref.92 Ref.97 Ref.106 Ref.111 Ref.117 Ref.119 May be O-glycosylated in the C-terminal basic region. Studied in EB-1 cell line. Ref.32 Ubiquitinated by MDM2 and SYVN1, which leads to proteasomal degradation. Ubiquitinated by RFWD3, which works in cooperation with MDM2 and may catalyze the formation of short polyubiquitin chains on p53/TP53 that are not targeted to the proteasome. Ubiquitinated by MKRN1 at Lys-291 and Lys-292, which leads to proteasomal degradation. Deubiquitinated by USP10, leading to its stabilization. Ubiquitinated by TRIM24, which leads to proteasomal degradation. Ubiquitination by TOPORS induces degradation. Deubiquitination by USP7, leading to stabilization. Isoform 4 is monoubiquitinated in an MDM2-independent manner. Ref.39 Ref.61 Ref.68 Ref.69 Ref.85 Ref.96 Ref.98 Ref.99 Ref.102 Ref.104 Ref.108 Ref.113 Monomethylated at Lys-372 by SETD7, leading to stabilization and increased transcriptional activation. Monomethylated at Lys-370 by SMYD2, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity. Lys-372 monomethylation prevents interaction with SMYD2 and subsequent monomethylation at Lys-370. Dimethylated at Lys-373 by EHMT1 and EHMT2. Monomethylated at Lys-382 by SETD8, promoting interaction with L3MBTL1 and leading to repress transcriptional activity. Dimethylation at Lys-370 and Lys-382 diminishes p53 ubiquitination, through stabilizing association with the methyl reader PHF20. Demethylation of dimethylated Lys-370 by KDM1A prevents interaction with TP53BP1 and represses TP53-mediated transcriptional activation. Ref.70 Ref.81 Ref.83 Ref.93 Ref.94 Ref.109 Ref.121 Ref.134 Sumoylated with SUMO1. Ref.35 Ref.51
Involvement in disease	TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is frequently mutated or inactivated in about 60% of cancers. TP53 defects are found in Barrett metaplasia a condition in which the normally stratified squamous epithelium of the lower esophagus is replaced by a metaplastic columnar epithelium. The condition develops as a complication in approximately 10% of patients with chronic gastroesophageal reflux disease and predisposes to the development of esophageal adenocarcinoma. Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. Note: The disease is caused by mutations affecting the gene represented in this entry. Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.38 Ref.146 Ref.147 Ref.148 Ref.149 Ref.150 Ref.169 Ref.171 Ref.176 Ref.177 Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note: The gene represented in this entry is involved in disease pathogenesis. Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note: The disease is caused by mutations affecting the gene represented in this entry. Choroid plexus papilloma (CPLPA) [MIM:260500]: Slow-growing benign tumor of the choroid plexus that often invades the leptomeninges. In children it is usually in a lateral ventricle but in adults it is more often in the fourth ventricle. Hydrocephalus is common, either from obstruction or from tumor secretion of cerebrospinal fluid. If it undergoes malignant transformation it is called a choroid plexus carcinoma. Primary choroid plexus tumors are rare and usually occur in early childhood. Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.180 Adrenocortical carcinoma (ADCC) [MIM:202300]: A malignant neoplasm of the adrenal cortex and a rare childhood tumor. It occurs with increased frequency in patients with Beckwith-Wiedemann syndrome and Li-Fraumeni syndrome. Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.179 Basal cell carcinoma 7 (BCC7) [MIM:614740]: A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter. Note: Disease susceptibility is associated with variations affecting the gene represented in this entry. Ref.118
Sequence similarities	Belongs to the p53 family.

Ontologies

Keywords
Biological process	Apoptosis Cell cycle Host-virus interaction Necrosis Transcription Transcription regulation
Cellular component	Cytoplasm Endoplasmic reticulum Mitochondrion Nucleus
Coding sequence diversity	Alternative promoter usage Alternative splicing Polymorphism
Disease	Disease mutation Li-Fraumeni syndrome Tumor suppressor
Ligand	DNA-binding Metal-binding Zinc
Molecular function	Activator
PTM	Acetylation Glycoprotein Isopeptide bond Methylation Phosphoprotein Ubl conjugation
Technical term	3D-structure Complete proteome Reference proteome
Gene Ontology (GO)
Biological_process	B cell lineage commitment Inferred from electronic annotation. Source: Compara DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest Traceable author statement. Source: Reactome DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator Inferred from mutant phenotype PubMed 7958916. Source: BHF-UCL DNA strand renaturation Inferred from direct assay PubMed 8183576. Source: UniProtKB ER overload response Inferred from direct assay PubMed 14744935. Source: MGI Ras protein signal transduction Inferred from expression pattern PubMed 9054499. Source: BHF-UCL T cell differentiation in thymus Inferred from electronic annotation. Source: Compara T cell lineage commitment Inferred from electronic annotation. Source: Compara T cell proliferation involved in immune response Inferred from electronic annotation. Source: Compara base-excision repair Traceable author statement PubMed 15116721. Source: UniProtKB blood coagulation Traceable author statement. Source: Reactome cell cycle arrest Inferred from mutant phenotype PubMed 10962037. Source: UniProtKB cell differentiation Traceable author statement PubMed 10065150. Source: UniProtKB cell proliferation Traceable author statement PubMed 10065150. Source: UniProtKB cellular protein localization Inferred from direct assay Ref.69. Source: UniProtKB cellular response to UV Inferred from Biological aspect of Ancestor. Source: RefGenome cellular response to drug Inferred from expression pattern PubMed 20810912. Source: UniProtKB cellular response to glucose starvation Inferred from direct assay PubMed 21471221. Source: UniProtKB cellular response to hypoxia Inferred from expression pattern PubMed 20810912. Source: UniProtKB cellular response to ionizing radiation Inferred from mutant phenotype PubMed 20160708. Source: BHF-UCL central nervous system development Inferred from electronic annotation. Source: Compara chromosome organization Inferred from electronic annotation. Source: Compara determination of adult lifespan Inferred from sequence or structural similarity. Source: BHF-UCL double-strand break repair Inferred from electronic annotation. Source: Compara gastrulation Inferred from electronic annotation. Source: Compara in utero embryonic development Inferred from electronic annotation. Source: Compara induction of apoptosis Inferred from electronic annotation. Source: Compara intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator Inferred from direct assay PubMed 17403783. Source: UniProtKB mitotic cell cycle arrest Inferred from electronic annotation. Source: Compara multicellular organism growth Inferred from electronic annotation. Source: Compara negative regulation of DNA replication Inferred from electronic annotation. Source: Compara negative regulation of apoptotic process Inferred from direct assay Ref.9. Source: UniProtKB negative regulation of cell growth Inferred from mutant phenotype PubMed 8986812. Source: UniProtKB negative regulation of fibroblast proliferation Inferred from mutant phenotype PubMed 10962037. Source: UniProtKB negative regulation of helicase activity Traceable author statement PubMed 7663514. Source: UniProtKB negative regulation of neuroblast proliferation Inferred from electronic annotation. Source: Compara negative regulation of transcription from RNA polymerase II promoter Inferred from direct assay Ref.69. Source: UniProtKB negative regulation of transforming growth factor beta receptor signaling pathway Inferred from electronic annotation. Source: Compara neuron apoptotic process Inferred from electronic annotation. Source: Compara nucleotide-excision repair Inferred from mutant phenotype PubMed 7663514. Source: UniProtKB oxidative stress-induced premature senescence Inferred from mutant phenotype PubMed 19951988. Source: BHF-UCL positive regulation of cell aging Inferred from electronic annotation. Source: Compara positive regulation of histone deacetylation Inferred from Biological aspect of Ancestor. Source: RefGenome positive regulation of intrinsic apoptotic signaling pathway Inferred from mutant phenotype PubMed 14963330. Source: UniProtKB positive regulation of neuron apoptotic process Inferred from Biological aspect of Ancestor. Source: RefGenome positive regulation of peptidyl-tyrosine phosphorylation Inferred from sequence or structural similarity PubMed 19749791. Source: BHF-UCL positive regulation of protein oligomerization Inferred from direct assay PubMed 12667443. Source: UniProtKB positive regulation of reactive oxygen species metabolic process Inferred from mutant phenotype PubMed 20160708. Source: BHF-UCL positive regulation of release of cytochrome c from mitochondria Inferred from direct assay PubMed 12667443PubMed 14963330. Source: UniProtKB positive regulation of thymocyte apoptotic process Inferred from sequence or structural similarity. Source: BHF-UCL positive regulation of transcription from RNA polymerase II promoter Inferred from direct assay Ref.9. Source: UniProtKB protein import into nucleus, translocation Inferred from electronic annotation. Source: Compara protein localization Inferred from direct assay PubMed 16507995. Source: UniProtKB protein tetramerization Traceable author statement PubMed 15116721. Source: UniProtKB rRNA transcription Inferred from electronic annotation. Source: Compara regulation of mitochondrial membrane permeability Traceable author statement PubMed 15116721. Source: UniProtKB release of cytochrome c from mitochondria Inferred from electronic annotation. Source: Compara replicative senescence Inferred from mutant phenotype PubMed 19951988. Source: BHF-UCL response to X-ray Inferred from Biological aspect of Ancestor. Source: RefGenome response to antibiotic Inferred from expression pattern PubMed 20810912. Source: UniProtKB response to gamma radiation Inferred from mutant phenotype PubMed 7958916. Source: BHF-UCL response to salt stress Inferred from electronic annotation. Source: Compara somitogenesis Inferred from electronic annotation. Source: Compara transforming growth factor beta receptor signaling pathway Inferred from electronic annotation. Source: Compara virus-host interaction Inferred from electronic annotation. Source: UniProtKB-KW
Cellular_component	PML body Inferred from direct assay PubMed 22869143. Source: UniProtKB cytoplasm Inferred from direct assay Ref.9Ref.69. Source: UniProtKB cytosol Inferred from direct assay PubMed 14963330. Source: UniProtKB endoplasmic reticulum Inferred from electronic annotation. Source: UniProtKB-SubCell mitochondrial matrix Inferred from electronic annotation. Source: UniProtKB-SubCell mitochondrion Inferred from direct assay PubMed 12667443. Source: UniProtKB nuclear chromatin Inferred from direct assay PubMed 15710329Ref.93PubMed 22521434. Source: BHF-UCL nuclear matrix Inferred from direct assay PubMed 11080164. Source: UniProtKB nucleolus Inferred from direct assay PubMed 12080348. Source: UniProtKB nucleus Inferred from direct assay Ref.9Ref.69. Source: UniProtKB protein complex Inferred from direct assay PubMed 9529249. Source: BHF-UCL replication fork Inferred from Biological aspect of Ancestor. Source: RefGenome
Molecular_function	ATP binding Inferred from direct assay PubMed 8183576. Source: UniProtKB RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription Inferred from electronic annotation. Source: Compara RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription Inferred from direct assay PubMed 17146433. Source: BHF-UCL chromatin binding Inferred from direct assay Ref.72. Source: UniProtKB copper ion binding Inferred from direct assay PubMed 7824276. Source: UniProtKB damaged DNA binding Inferred from Biological aspect of Ancestor. Source: RefGenome histone deacetylase regulator activity Inferred from electronic annotation. Source: Compara p53 binding Inferred from Biological aspect of Ancestor. Source: RefGenome transcription regulatory region DNA binding Inferred from direct assay PubMed 15710329PubMed 17996705. Source: BHF-UCL zinc ion binding Traceable author statement PubMed 10065153. Source: UniProtKB
Complete GO annotation...

Binary interactions

With	Entry	#Exp.	IntAct	Notes
itself		4	EBI-366083,EBI-366083
	P03070	6	EBI-366083,EBI-617698	From a different organism.
AXIN1	O15169	4	EBI-366083,EBI-710484
BCL2	P10415	3	EBI-366083,EBI-77694
BCL2L1	Q07817-1	18	EBI-366083,EBI-287195
BRD7	Q9NPI1	8	EBI-366083,EBI-711221
BTBD2	Q9BX70	2	EBI-366083,EBI-710091
Cables1	Q9ESJ1	3	EBI-366083,EBI-604411	From a different organism.
CEBPB	P17676	4	EBI-366083,EBI-969696
CREBBP	Q92793	6	EBI-366083,EBI-81215
Crebbp	P45481	6	EBI-366083,EBI-296306	From a different organism.
CSE1L	P55060	5	EBI-366083,EBI-286709
CUL7	Q14999	3	EBI-366083,EBI-308606
CUL9	Q8IWT3	2	EBI-366083,EBI-311123
DAXX	Q9UER7	11	EBI-366083,EBI-77321
DDX17	Q92841	3	EBI-366083,EBI-746012
DDX5	P17844	3	EBI-366083,EBI-351962
DUSP26	Q9BV47	9	EBI-366083,EBI-2924519
EP300	Q09472	7	EBI-366083,EBI-447295
FBXO11	Q86XK2	4	EBI-366083,EBI-1047804
HDAC1	Q13547	3	EBI-366083,EBI-301834
HIPK1	Q86Z02	2	EBI-366083,EBI-692891
HNRNPUL1	Q9BUJ2	11	EBI-366083,EBI-1018153
HSPA9	P38646	2	EBI-366083,EBI-354932
HTT	P42858	4	EBI-366083,EBI-466029
HUWE1	Q7Z6Z7	3	EBI-366083,EBI-625934
IFI16	Q16666-2	3	EBI-366083,EBI-6273540
KAT5	Q92993	3	EBI-366083,EBI-399080
MAGEA2B	P43356	6	EBI-366083,EBI-5650739
MAGEC2	Q9UBF1	3	EBI-366083,EBI-5651487
MAPK11	Q15759	2	EBI-366083,EBI-298304
MAPKAPK5	Q8IW41	2	EBI-366083,EBI-1201460
MDM2	Q00987	29	EBI-366083,EBI-389668
MDM4	O15151	4	EBI-366083,EBI-398437
MLL5	Q8IZD2	4	EBI-366083,EBI-2689959
NFYA	P23511	11	EBI-366083,EBI-389739
NOC2L	Q9Y3T9	8	EBI-366083,EBI-751547
NPM1	P06748	3	EBI-366083,EBI-78579
NPM1	P06748-1	3	EBI-366083,EBI-354150
NUAK1	O60285	5	EBI-366083,EBI-1046789
PARP1	P09874	3	EBI-366083,EBI-355676
PBK	Q96KB5	7	EBI-366083,EBI-536853
PIAS1	O75925	3	EBI-366083,EBI-629434
PIAS4	Q8N2W9	2	EBI-366083,EBI-473160
PIN1	Q13526	11	EBI-366083,EBI-714158
PML	P29590	3	EBI-366083,EBI-295890
PPIF	P30405	4	EBI-366083,EBI-5544229
PPP1CC	P36873-1	2	EBI-366083,EBI-356289
PPP1R13L	Q8WUF5	3	EBI-366083,EBI-5550163
PTK2	Q05397	11	EBI-366083,EBI-702142
RAD51	Q06609	2	EBI-366083,EBI-297202
SETD7	Q8WTS6	6	EBI-366083,EBI-1268586
SIN3A	Q96ST3	2	EBI-366083,EBI-347218
SIRT1	Q96EB6	13	EBI-366083,EBI-1802965
Sirt1	Q923E4	4	EBI-366083,EBI-1802585	From a different organism.
SREBF2	Q12772	3	EBI-366083,EBI-465059
TBP	P20226	2	EBI-366083,EBI-355371
TP63	Q9H3D4	5	EBI-366083,EBI-2337775
Tp63	O88898	2	EBI-366083,EBI-2338025	From a different organism.
TWIST1	Q15672	9	EBI-366083,EBI-1797287
Twist1	P26687	4	EBI-366083,EBI-6123119	From a different organism.
UBE3A	Q05086	2	EBI-366083,EBI-954357
UHRF2	Q96PU4	3	EBI-366083,EBI-625304
USP7	Q93009	10	EBI-366083,EBI-302474
VDR	P11473	6	EBI-366083,EBI-286357
WRN	Q14191	5	EBI-366083,EBI-368417
XRCC6	P12956	2	EBI-366083,EBI-353208
znf585b	Q9PST7	3	EBI-366083,EBI-1782562	From a different organism.

Alternative products

This entry describes 9 isoforms produced by alternative promoter usage and alternative splicing. [Align] [Select]

Isoform 1 (identifier: P04637-1)

Also known as: p53; p53alpha;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Isoform 2 (identifier: P04637-2)

Also known as: I9RET; p53beta;

The sequence of this isoform differs from the canonical sequence as follows:
     332-341: IRGRERFEMF → DQTSFQKENC
     342-393: Missing.

Note: Expressed in quiescent lymphocytes. Seems to be non-functional. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoform 3 (identifier: P04637-3)

Also known as: p53gamma;

The sequence of this isoform differs from the canonical sequence as follows:
     332-346: IRGRERFEMFRELNE → MLLDLRWCYFLINSS
     347-393: Missing.

Note: Expressed in quiescent lymphocytes. Seems to be non-functional. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoform 4 (identifier: P04637-4)

Also known as: Del40-p53; Del40-p53alpha; p47;

The sequence of this isoform differs from the canonical sequence as follows:
     1-39: Missing.

Isoform 5 (identifier: P04637-5)

Also known as: Del40-p53beta;

The sequence of this isoform differs from the canonical sequence as follows:
     1-39: Missing.
     332-341: IRGRERFEMF → DQTSFQKENC
     342-393: Missing.

Isoform 6 (identifier: P04637-6)

Also known as: Del40-p53gamma;

The sequence of this isoform differs from the canonical sequence as follows:
     1-39: Missing.
     332-346: IRGRERFEMFRELNE → MLLDLRWCYFLINSS
     347-393: Missing.

Isoform 7 (identifier: P04637-7)

Also known as: Del133-p53; Del133-p53alpha;

The sequence of this isoform differs from the canonical sequence as follows:
     1-132: Missing.

Note: Produced by alternative promoter usage.

Isoform 8 (identifier: P04637-8)

Also known as: Del133-p53beta;

The sequence of this isoform differs from the canonical sequence as follows:
     1-132: Missing.
     332-341: IRGRERFEMF → DQTSFQKENC
     342-393: Missing.

Note: Produced by alternative promoter usage and alternative splicing.

Isoform 9 (identifier: P04637-9)

Also known as: Del133-p53gamma;

The sequence of this isoform differs from the canonical sequence as follows:
     1-132: Missing.
     332-346: IRGRERFEMFRELNE → MLLDLRWCYFLINSS
     347-393: Missing.

Note: Produced by alternative promoter usage and alternative splicing.

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 393	393	Cellular tumor antigen p53		PRO_0000185703
Regions
	DNA binding	102 – 292	191
	Region	1 – 83	83	Interaction with HRMT1L2
	Region	1 – 44	44	Transcription activation (acidic)
	Region	66 – 110	45	Interaction with WWOX
	Region	100 – 370	271	Interaction with HIPK1 By similarity
	Region	113 – 236	124	Required for interaction with FBXO42
	Region	116 – 292	177	Interaction with AXIN1 By similarity
	Region	241 – 248	8	Interacts with the 53BP2 SH3 domain
	Region	256 – 294	39	Interaction with E4F1
	Region	273 – 280	8	Interaction with DNA
	Region	300 – 393	94	Interaction with CARM1
	Region	319 – 360	42	Interaction with HIPK2
	Region	325 – 356	32	Oligomerization
	Region	359 – 363	5	Interaction with USP7
	Region	368 – 387	20	Basic (repression of DNA-binding)
	Motif	17 – 25	9	TADI
	Motif	48 – 56	9	TADII
	Motif	305 – 321	17	Bipartite nuclear localization signal
	Motif	339 – 350	12	Nuclear export signal
	Motif	370 – 372	3	[KR]-[STA]-K motif
Sites
	Metal binding	176	1	Zinc
	Metal binding	179	1	Zinc
	Metal binding	238	1	Zinc
	Metal binding	242	1	Zinc
	Site	120	1	Interaction with DNA
Amino acid modifications
	Modified residue	9	1	Phosphoserine; by HIPK4 Ref.88
	Modified residue	15	1	Phosphoserine; by CDK5, PRPK, AMPK, NUAK1 and ATM Ref.38 Ref.46 Ref.73 Ref.76 Ref.77 Ref.91 Ref.97 Ref.119
	Modified residue	18	1	Phosphothreonine; by CK1, VRK1 and VRK2 Ref.36 Ref.44 Ref.78
	Modified residue	20	1	Phosphoserine; by CHEK2, CK1 and PLK3 Ref.38 Ref.49 Ref.50 Ref.61 Ref.106
	Modified residue	33	1	Phosphoserine; by CDK5 and CDK7 Ref.33 Ref.91
	Modified residue	37	1	Phosphoserine; by MAPKAPK5 Ref.84
	Modified residue	46	1	Phosphoserine; by CDK5, DYRK2, HIPK2 and PKC/PRKCG Ref.57 Ref.58 Ref.80 Ref.91 Ref.92
	Modified residue	55	1	Phosphothreonine; by TAF1 and GRK5 Ref.67 Ref.111
	Modified residue	120	1	N6-acetyllysine; by KAT6A Ref.122
	Modified residue	183	1	Phosphoserine; by AURKB Ref.117
	Modified residue	269	1	Phosphoserine; by AURKB Ref.117
	Modified residue	284	1	Phosphothreonine; by AURKB Ref.117
	Modified residue	305	1	N6-acetyllysine Ref.60
	Modified residue	315	1	Phosphoserine; by AURKA, CDK1 and CDK2 Ref.41 Ref.71
	Modified residue	370	1	N6,N6-dimethyllysine; alternate Ref.81 Ref.121
	Modified residue	370	1	N6-methyllysine; by SMYD2; alternate Ref.81 Ref.121
	Modified residue	372	1	N6-methyllysine; by SETD7 Ref.70 Ref.83
	Modified residue	373	1	N6,N6-dimethyllysine; by EHMT1 and EHMT2; alternate Ref.109
	Modified residue	373	1	N6-acetyllysine; alternate Ref.40
	Modified residue	381	1	N6-acetyllysine Ref.103
	Modified residue	382	1	N6,N6-dimethyllysine; alternate Ref.94 Ref.121 Ref.134
	Modified residue	382	1	N6-acetyllysine; by KAT6A; alternate Ref.40 Ref.47 Ref.103 Ref.112 Ref.122
	Modified residue	382	1	N6-methyllysine; by SETD8; alternate Ref.94 Ref.121 Ref.134
	Modified residue	392	1	Phosphoserine; by CK2, CDK2 and NUAK1 Ref.41 Ref.53 Ref.77 Ref.119
	Cross-link	291		Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.98
	Cross-link	292		Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.98
	Cross-link	386		Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.35 Ref.51
Natural variations
	Alternative sequence	1 – 132	132	Missing in isoform 7, isoform 8 and isoform 9.		VSP_040833
	Alternative sequence	1 – 39	39	Missing in isoform 4, isoform 5 and isoform 6.		VSP_040832
	Alternative sequence	332 – 346	15	IRGRE…RELNE → MLLDLRWCYFLINSS in isoform 3, isoform 6 and isoform 9.		VSP_040560
	Alternative sequence	332 – 341	10	IRGRERFEMF → DQTSFQKENC in isoform 2, isoform 5 and isoform 8.		VSP_006535
	Alternative sequence	342 – 393	52	Missing in isoform 2, isoform 5 and isoform 8.		VSP_006536
	Alternative sequence	347 – 393	47	Missing in isoform 3, isoform 6 and isoform 9.		VSP_040561
	Natural variant	5	1	Q → H in a sporadic cancer; somatic mutation; abolishes strongly phosphorylation.		VAR_044543
	Natural variant	6	1	S → L in a sporadic cancer; somatic mutation.		VAR_044544
	Natural variant	7	1	D → H in a sporadic cancer; somatic mutation.		VAR_005851
	Natural variant	8	1	P → S in a sporadic cancer; somatic mutation.		VAR_044545
	Natural variant	10	1	V → I in a sporadic cancer; somatic mutation.		VAR_044546
	Natural variant	11	1	E → K in sporadic cancers; somatic mutation.		VAR_044547
	Natural variant	11	1	E → Q in sporadic cancers; somatic mutation.		VAR_044548
	Natural variant	15	1	S → R in a sporadic cancer; somatic mutation.		VAR_044549
	Natural variant	16	1	Q → L in a sporadic cancer; somatic mutation.		VAR_044550
	Natural variant	17	1	E → D in a sporadic cancer; somatic mutation.		VAR_044551
	Natural variant	24	1	K → N in a sporadic cancer; somatic mutation.		VAR_044552
	Natural variant	28	1	E → A in a sporadic cancer; somatic mutation.		VAR_044553
	Natural variant	29 – 30	2	NN → KD in a sporadic cancer; somatic mutation.		VAR_047158
	Natural variant	31	1	V → I in sporadic cancers; somatic mutation.		VAR_044554
	Natural variant	33	1	S → T in a sporadic cancer; somatic mutation.		VAR_044555
	Natural variant	34	1	P → L in a sporadic cancer; somatic mutation.		VAR_044556
	Natural variant	35	1	L → F in sporadic cancers; somatic mutation.		VAR_005852
	Natural variant	36	1	P → L in a sporadic cancer; somatic mutation.		VAR_044557
	Natural variant	37	1	S → P in a sporadic cancer; somatic mutation.		VAR_044558
	Natural variant	37	1	S → T in a sporadic cancer; somatic mutation.		VAR_044559
	Natural variant	39	1	A → P in a sporadic cancer; somatic mutation.		VAR_044560
	Natural variant	39	1	A → V in a sporadic cancer; somatic mutation.		VAR_044561
	Natural variant	42	1	D → Y in a sporadic cancer; somatic mutation.		VAR_044562
	Natural variant	43	1	L → S in a sporadic cancer; somatic mutation.		VAR_005853
	Natural variant	44	1	M → I in a sporadic cancer; somatic mutation.		VAR_044563
	Natural variant	44	1	M → T in a sporadic cancer; somatic mutation.		VAR_044564
	Natural variant	44	1	M → V in a sporadic cancer; somatic mutation.		VAR_044565
	Natural variant	45	1	L → M in a sporadic cancer; somatic mutation.		VAR_044566
	Natural variant	46	1	S → F in sporadic cancers; somatic mutation.		VAR_044567
	Natural variant	46	1	S → P in sporadic cancers; somatic mutation.		VAR_044568
	Natural variant	47	1	P → L in sporadic cancers; somatic mutation.		VAR_044569
	Natural variant	47	1	P → S. Ref.12 Corresponds to variant rs1800371 [ dbSNP | Ensembl ].		VAR_014632
	Natural variant	48	1	D → G in a sporadic cancer; somatic mutation.		VAR_044570
	Natural variant	49	1	D → H in sporadic cancers; somatic mutation.		VAR_044571
	Natural variant	49	1	D → N in a sporadic cancer; somatic mutation.		VAR_044572
	Natural variant	49	1	D → Y in sporadic cancers; somatic mutation.		VAR_044573
	Natural variant	52	1	Q → H in a sporadic cancer; somatic mutation.		VAR_044574
	Natural variant	53	1	W → C in sporadic cancers; somatic mutation.		VAR_005854
	Natural variant	53	1	W → G in a sporadic cancer; somatic mutation.		VAR_044575
	Natural variant	54	1	F → L in a sporadic cancer; somatic mutation.		VAR_044576
	Natural variant	54	1	F → Y in a sporadic cancer; somatic mutation.		VAR_044577
	Natural variant	56	1	E → K in sporadic cancers; somatic mutation.		VAR_044578
	Natural variant	56	1	E → V in a sporadic cancer; somatic mutation.		VAR_044579
	Natural variant	58	1	P → Q in a sporadic cancer; somatic mutation.		VAR_044580
	Natural variant	58	1	P → T in a sporadic cancer; somatic mutation.		VAR_044581
	Natural variant	59	1	G → C in sporadic cancers; somatic mutation.		VAR_044582
	Natural variant	59	1	G → D in sporadic cancers; somatic mutation.		VAR_044583
	Natural variant	59	1	G → N in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045783
	Natural variant	60	1	P → L in sporadic cancers; somatic mutation.		VAR_044584
	Natural variant	60	1	P → Q in a sporadic cancer; somatic mutation.		VAR_044585
	Natural variant	60	1	P → S in a sporadic cancer; somatic mutation.		VAR_005855
	Natural variant	61	1	D → G in sporadic cancers; somatic mutation.		VAR_044586
	Natural variant	61	1	D → N in sporadic cancers; somatic mutation.		VAR_044587
	Natural variant	62	1	E → D in a sporadic cancer; somatic mutation.		VAR_044588
	Natural variant	63	1	A → T in a sporadic cancer; somatic mutation.		VAR_044589
	Natural variant	63	1	A → V in a sporadic cancer; somatic mutation.		VAR_044590
	Natural variant	65	1	R → T in a sporadic cancer; somatic mutation.		VAR_044591
	Natural variant	66	1	M → I in a sporadic cancer; somatic mutation.		VAR_044592
	Natural variant	66	1	M → R in a sporadic cancer; somatic mutation.		VAR_044593
	Natural variant	67	1	P → L in sporadic cancers; somatic mutation.		VAR_044594
	Natural variant	67	1	P → R in a sporadic cancer; somatic mutation.		VAR_044595
	Natural variant	67	1	P → S in sporadic cancers; somatic mutation.		VAR_044596
	Natural variant	68	1	E → G in sporadic cancers; somatic mutation.		VAR_044597
	Natural variant	68	1	E → Q in a sporadic cancer; somatic mutation.		VAR_044598
	Natural variant	69	1	A → D in a sporadic cancer; somatic mutation.		VAR_044599
	Natural variant	69	1	A → G in sporadic cancers; somatic mutation.		VAR_044600
	Natural variant	69	1	A → T in a sporadic cancer; somatic mutation.		VAR_044601
	Natural variant	69	1	A → V in a sporadic cancer; somatic mutation.		VAR_044602
	Natural variant	70	1	A → T in a sporadic cancer; somatic mutation.		VAR_044603
	Natural variant	71	1	P → T in a sporadic cancer; somatic mutation.		VAR_044604
	Natural variant	72	1	P → C in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions.		VAR_045784
	Natural variant	72	1	P → G in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions.		VAR_045785
	Natural variant	72	1	P → H in sporadic cancers; somatic mutation.		VAR_045786
	Natural variant	72	1	P → L in a sporadic cancer; somatic mutation.		VAR_045787
	Natural variant	72	1	P → R. Ref.9 Ref.15 Ref.17 Ref.145 Corresponds to variant rs1042522 [ dbSNP | Ensembl ].		VAR_005856
	Natural variant	73	1	V → E in a sporadic cancer; somatic mutation.		VAR_044605
	Natural variant	73	1	V → L in sporadic cancers; somatic mutation.		VAR_044606
	Natural variant	73	1	V → M in sporadic cancers; somatic mutation.		VAR_044607
	Natural variant	74	1	A → T in a sporadic cancer; somatic mutation.		VAR_044608
	Natural variant	75	1	P → L in sporadic cancers; somatic mutation.		VAR_044609
	Natural variant	75	1	P → R in sporadic cancers; somatic mutation.		VAR_044610
	Natural variant	75	1	P → S in a sporadic cancer; somatic mutation.		VAR_044611
	Natural variant	76	1	A → G in a sporadic cancer; somatic mutation.		VAR_044612
	Natural variant	76	1	A → T in a sporadic cancer; somatic mutation.		VAR_044613
	Natural variant	77	1	P → A in sporadic cancers; somatic mutation.		VAR_044614
	Natural variant	78	1	A → V in sporadic cancers; somatic mutation.		VAR_044615
	Natural variant	79	1	A → G in a sporadic cancer; somatic mutation.		VAR_044616
	Natural variant	79	1	A → T in a sporadic cancer; somatic mutation.		VAR_005857
	Natural variant	79	1	A → V in sporadic cancers; somatic mutation.		VAR_044617
	Natural variant	80	1	P → L in a sporadic cancer; somatic mutation.		VAR_044618
	Natural variant	80	1	P → S in a sporadic cancer; somatic mutation.		VAR_044619
	Natural variant	81	1	T → I in sporadic cancers; somatic mutation.		VAR_044620
	Natural variant	82	1	P → L in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044621
	Natural variant	82	1	P → S in sporadic cancers; somatic mutation.		VAR_044622
	Natural variant	83	1	A → E in a sporadic cancer; somatic mutation.		VAR_044623
	Natural variant	83	1	A → V in sporadic cancers; somatic mutation.		VAR_044624
	Natural variant	84	1	A → G in sporadic cancers; somatic mutation.		VAR_044625
	Natural variant	84	1	A → V in sporadic cancers; somatic mutation.		VAR_044626
	Natural variant	85	1	P → L in sporadic cancers; somatic mutation.		VAR_044627
	Natural variant	85	1	P → S in sporadic cancers; somatic mutation.		VAR_044628
	Natural variant	86	1	A → V in a sporadic cancer; somatic mutation.		VAR_044629
	Natural variant	87	1	P → Q in sporadic cancers; somatic mutation.		VAR_005858
	Natural variant	88	1	A → T in a sporadic cancer; somatic mutation.		VAR_044630
	Natural variant	88	1	A → V in sporadic cancers; somatic mutation.		VAR_044631
	Natural variant	89	1	P → L in sporadic cancers; somatic mutation.		VAR_044632
	Natural variant	89	1	P → S in sporadic cancers; somatic mutation.		VAR_044633
	Natural variant	90	1	S → F in sporadic cancers; somatic mutation.		VAR_044634
	Natural variant	90	1	S → Y in a sporadic cancer; somatic mutation.		VAR_044635
	Natural variant	91	1	W → C in a sporadic cancer; somatic mutation.		VAR_044636
	Natural variant	92	1	P → A in a sporadic cancer; somatic mutation.		VAR_044637
	Natural variant	92	1	P → L in a sporadic cancer; somatic mutation.		VAR_044638
	Natural variant	92	1	P → S in a sporadic cancer; somatic mutation.		VAR_044639
	Natural variant	93	1	L → M in a sporadic cancer; somatic mutation.		VAR_044640
	Natural variant	93	1	L → P in a sporadic cancer; somatic mutation.		VAR_044641
	Natural variant	94	1	S → L in sporadic cancers; somatic mutation.		VAR_044642
	Natural variant	94	1	S → T in sporadic cancers; somatic mutation.		VAR_005859
	Natural variant	95	1	S → F in sporadic cancers; somatic mutation.		VAR_044643
	Natural variant	95	1	S → T in a sporadic cancer; somatic mutation.		VAR_044644
	Natural variant	96	1	S → C in a sporadic cancer; somatic mutation.		VAR_044645
	Natural variant	96	1	S → F in sporadic cancers; somatic mutation.		VAR_044646
	Natural variant	96	1	S → P in a sporadic cancer; somatic mutation.		VAR_044647
	Natural variant	97	1	V → A in a sporadic cancer; somatic mutation.		VAR_044648
	Natural variant	97	1	V → F in a sporadic cancer; somatic mutation.		VAR_044649
	Natural variant	97	1	V → I in familial cancer not matching LFS; germline mutation and in a sporadic cancer; somatic mutation.		VAR_044650
	Natural variant	98	1	P → L in sporadic cancers; somatic mutation.		VAR_044651
	Natural variant	98	1	P → S in sporadic cancers; somatic mutation.		VAR_044652
	Natural variant	99	1	S → F in sporadic cancers; somatic mutation.		VAR_044653
	Natural variant	99	1	S → P in a sporadic cancer; somatic mutation.		VAR_044654
	Natural variant	100	1	Q → R in a sporadic cancer; somatic mutation.		VAR_044655
	Natural variant	101	1	K → N in a sporadic cancer; somatic mutation.		VAR_044656
	Natural variant	101	1	K → R in sporadic cancers; somatic mutation.		VAR_044657
	Natural variant	102	1	T → I in sporadic cancers; somatic mutation.		VAR_044658
	Natural variant	104	1	Q → H in sporadic cancers; somatic mutation.		VAR_044659
	Natural variant	104	1	Q → L in a sporadic cancer; somatic mutation.		VAR_044660
	Natural variant	105	1	G → C in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044661
	Natural variant	105	1	G → D in sporadic cancers; somatic mutation.		VAR_044662
	Natural variant	105	1	G → R in sporadic cancers; somatic mutation.		VAR_044663
	Natural variant	105	1	G → S in a sporadic cancer; somatic mutation.		VAR_044664
	Natural variant	105	1	G → V in sporadic cancers; somatic mutation.		VAR_044665
	Natural variant	106	1	S → G in a sporadic cancer; somatic mutation.		VAR_044666
	Natural variant	106	1	S → R in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044667
	Natural variant	107	1	Y → C in a sporadic cancer; somatic mutation.		VAR_044668
	Natural variant	107	1	Y → D in sporadic cancers; somatic mutation.		VAR_044669
	Natural variant	107	1	Y → H in a sporadic cancer; somatic mutation.		VAR_044670
	Natural variant	108	1	G → D in a sporadic cancer; somatic mutation.		VAR_044671
	Natural variant	108	1	G → S in sporadic cancers; somatic mutation.		VAR_044672
	Natural variant	109	1	F → C in sporadic cancers; somatic mutation.		VAR_044673
	Natural variant	109	1	F → L in a sporadic cancer; somatic mutation.		VAR_044674
	Natural variant	109	1	F → S in sporadic cancers; somatic mutation.		VAR_044675
	Natural variant	110	1	R → C in sporadic cancers; somatic mutation.		VAR_005860
	Natural variant	110	1	R → G in a sporadic cancer; somatic mutation.		VAR_044676
	Natural variant	110	1	R → H in sporadic cancers; somatic mutation.		VAR_044677
	Natural variant	110	1	R → L in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; does not induce SNAI1 degradation. Ref.107		VAR_005861
	Natural variant	110	1	R → P in sporadic cancers; somatic mutation. Corresponds to variant rs11540654 [ dbSNP | Ensembl ].		VAR_005862
	Natural variant	110	1	R → S in a sporadic cancer; somatic mutation.		VAR_044678
	Natural variant	111	1	L → M in a sporadic cancer; somatic mutation.		VAR_044679
	Natural variant	111	1	L → P in sporadic cancers; somatic mutation.		VAR_044680
	Natural variant	111	1	L → Q in sporadic cancers; somatic mutation.		VAR_044681
	Natural variant	111	1	L → R in sporadic cancers; somatic mutation.		VAR_044682
	Natural variant	112	1	G → D in sporadic cancers; somatic mutation.		VAR_044683
	Natural variant	112	1	G → S in sporadic cancers; somatic mutation.		VAR_044684
	Natural variant	113	1	F → C in sporadic cancers; somatic mutation.		VAR_005863
	Natural variant	113	1	F → G in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045788
	Natural variant	113	1	F → I in a sporadic cancer; somatic mutation.		VAR_044685
	Natural variant	113	1	F → L in sporadic cancers; somatic mutation.		VAR_044686
	Natural variant	113	1	F → S in sporadic cancers; somatic mutation.		VAR_044687
	Natural variant	113	1	F → V in sporadic cancers; somatic mutation.		VAR_033033
	Natural variant	115	1	H → Y in sporadic cancers; somatic mutation.		VAR_044688
	Natural variant	116	1	S → C in sporadic cancers; somatic mutation.		VAR_044689
	Natural variant	116	1	S → F in a sporadic cancer; somatic mutation.		VAR_044690
	Natural variant	116	1	S → P in a sporadic cancer; somatic mutation.		VAR_044691
	Natural variant	117	1	G → E in sporadic cancers; somatic mutation.		VAR_044692
	Natural variant	117	1	G → R in sporadic cancers; somatic mutation.		VAR_044693
	Natural variant	118	1	T → A in a sporadic cancer; somatic mutation.		VAR_044694
	Natural variant	118	1	T → I in sporadic cancers; somatic mutation.		VAR_044695
	Natural variant	118	1	T → R in a sporadic cancer; somatic mutation.		VAR_044696
	Natural variant	119	1	A → D in a sporadic cancer; somatic mutation.		VAR_044697
	Natural variant	119	1	A → T in a sporadic cancer; somatic mutation.		VAR_044698
	Natural variant	120	1	K → E in sporadic cancers; somatic mutation.		VAR_044699
	Natural variant	120	1	K → M in sporadic cancers; somatic mutation.		VAR_044700
	Natural variant	120	1	K → Q in a sporadic cancer; somatic mutation.		VAR_044701
	Natural variant	120	1	K → R in sporadic cancers; somatic mutation.		VAR_044702
	Natural variant	121	1	S → F in sporadic cancers; somatic mutation.		VAR_044703
	Natural variant	122	1	V → L in a sporadic cancer; somatic mutation.		VAR_044704
	Natural variant	123	1	T → I in a sporadic cancer; somatic mutation.		VAR_044705
	Natural variant	123	1	T → N in a sporadic cancer; somatic mutation.		VAR_044706
	Natural variant	124	1	C → G in a sporadic cancer; somatic mutation.		VAR_044707
	Natural variant	124	1	C → R in sporadic cancers; somatic mutation.		VAR_044708
	Natural variant	124	1	C → S in sporadic cancers; somatic mutation.		VAR_044709
	Natural variant	124	1	C → W in a sporadic cancer; somatic mutation.		VAR_044710
	Natural variant	124	1	C → Y in a sporadic cancer; somatic mutation.		VAR_044711
	Natural variant	125	1	T → A in a sporadic cancer; somatic mutation.		VAR_044712
	Natural variant	125	1	T → K in sporadic cancers; somatic mutation.		VAR_044713
	Natural variant	125	1	T → M in sporadic cancers; somatic mutation.		VAR_005864
	Natural variant	125	1	T → P in a sporadic cancer; somatic mutation.		VAR_044714
	Natural variant	125	1	T → R in sporadic cancers; somatic mutation.		VAR_044715
	Natural variant	126	1	Y → C in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044716
	Natural variant	126	1	Y → D in sporadic cancers; somatic mutation.		VAR_005865
	Natural variant	126	1	Y → F in a sporadic cancer; somatic mutation.		VAR_044717
	Natural variant	126	1	Y → G in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045789
	Natural variant	126	1	Y → H in sporadic cancers; somatic mutation.		VAR_044718
	Natural variant	126	1	Y → N in sporadic cancers; somatic mutation.		VAR_005866
	Natural variant	126	1	Y → S in sporadic cancers; somatic mutation.		VAR_044719
	Natural variant	127	1	S → C in a sporadic cancer; somatic mutation.		VAR_044720
	Natural variant	127	1	S → F in sporadic cancers; somatic mutation.		VAR_005867
	Natural variant	127	1	S → P in sporadic cancers; somatic mutation.		VAR_044721
	Natural variant	127	1	S → T in sporadic cancers; somatic mutation.		VAR_044722
	Natural variant	127	1	S → Y in sporadic cancers; somatic mutation.		VAR_044723
	Natural variant	128	1	P → A in sporadic cancers; somatic mutation.		VAR_044724
	Natural variant	128	1	P → L in sporadic cancers; somatic mutation.		VAR_044725
	Natural variant	128	1	P → R in sporadic cancers; somatic mutation.		VAR_044726
	Natural variant	128	1	P → S in sporadic cancers; somatic mutation.		VAR_005868
	Natural variant	129	1	A → D in sporadic cancers; somatic mutation.		VAR_005869
	Natural variant	129	1	A → G in a sporadic cancer; somatic mutation.		VAR_044727
	Natural variant	129	1	A → T in sporadic cancers; somatic mutation.		VAR_044728
	Natural variant	129	1	A → V in sporadic cancers; somatic mutation.		VAR_044729
	Natural variant	130	1	L → F in sporadic cancers; somatic mutation.		VAR_044730
	Natural variant	130	1	L → H in sporadic cancers; somatic mutation.		VAR_044731
	Natural variant	130	1	L → I in a sporadic cancer; somatic mutation.		VAR_044732
	Natural variant	130	1	L → P in sporadic cancers; somatic mutation.		VAR_044733
	Natural variant	130	1	L → R in sporadic cancers; somatic mutation.		VAR_005870
	Natural variant	130	1	L → V in sporadic cancers; somatic mutation.		VAR_044734
	Natural variant	131	1	N → D in a sporadic cancer; somatic mutation.		VAR_044735
	Natural variant	131	1	N → H in sporadic cancers; somatic mutation.		VAR_044736
	Natural variant	131	1	N → I in sporadic cancers; somatic mutation.		VAR_044737
	Natural variant	131	1	N → K in sporadic cancers; somatic mutation.		VAR_005872
	Natural variant	131	1	N → S in sporadic cancers; somatic mutation.		VAR_005871
	Natural variant	131	1	N → T in a sporadic cancer; somatic mutation.		VAR_044738
	Natural variant	131	1	N → Y in sporadic cancers; somatic mutation.		VAR_044739
	Natural variant	132 – 133	2	KM → NL in a sporadic cancer; somatic mutation.		VAR_047159
	Natural variant	132	1	K → E in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044740
	Natural variant	132	1	K → L in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045790
	Natural variant	132	1	K → M in sporadic cancers; somatic mutation.		VAR_005873
	Natural variant	132	1	K → N in sporadic cancers; somatic mutation.		VAR_044741
	Natural variant	132	1	K → Q in sporadic cancers; somatic mutation.		VAR_005874
	Natural variant	132	1	K → R in sporadic cancers; somatic mutation.		VAR_044742
	Natural variant	132	1	K → T in sporadic cancers; somatic mutation.		VAR_044743
	Natural variant	132	1	K → W in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045791
	Natural variant	133	1	M → I in sporadic cancers; somatic mutation.		VAR_044744
	Natural variant	133	1	M → K in sporadic cancers; somatic mutation.		VAR_044745
	Natural variant	133	1	M → L in sporadic cancers; somatic mutation.		VAR_044746
	Natural variant	133	1	M → R in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044747
	Natural variant	133	1	M → T in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.146 Corresponds to variant rs28934873 [ dbSNP | Ensembl ].		VAR_005875
	Natural variant	133	1	M → V in sporadic cancers; somatic mutation.		VAR_044748
	Natural variant	134	1	F → C in sporadic cancers; somatic mutation.		VAR_044749
	Natural variant	134	1	F → I in sporadic cancers; somatic mutation.		VAR_044750
	Natural variant	134	1	F → L in sporadic cancers; somatic mutation.		VAR_036504
	Natural variant	134	1	F → S in sporadic cancers; somatic mutation.		VAR_044751
	Natural variant	134	1	F → V in sporadic cancers; somatic mutation.		VAR_044752
	Natural variant	135	1	C → F in sporadic cancers; somatic mutation.		VAR_005877
	Natural variant	135	1	C → G in sporadic cancers; somatic mutation.		VAR_044753
	Natural variant	135	1	C → R in sporadic cancers; somatic mutation.		VAR_044754
	Natural variant	135	1	C → S in sporadic cancers; somatic mutation.		VAR_005876
	Natural variant	135	1	C → T in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045792
	Natural variant	135	1	C → W in sporadic cancers; somatic mutation.		VAR_044755
	Natural variant	135	1	C → Y in sporadic cancers; somatic mutation; decreased E6-mediated binding to E6-AP.		VAR_044756
	Natural variant	136	1	Q → E in sporadic cancers; somatic mutation.		VAR_005878
	Natural variant	136	1	Q → H in sporadic cancers; somatic mutation.		VAR_044757
	Natural variant	136	1	Q → K in a sporadic cancer; somatic mutation.		VAR_005879
	Natural variant	136	1	Q → P in sporadic cancers; somatic mutation.		VAR_044758
	Natural variant	136	1	Q → R in sporadic cancers; somatic mutation.		VAR_044759
	Natural variant	137	1	L → M in sporadic cancers; somatic mutation.		VAR_044760
	Natural variant	137	1	L → P in sporadic cancers; somatic mutation.		VAR_044761
	Natural variant	137	1	L → Q in sporadic cancers; somatic mutation.		VAR_005880
	Natural variant	137	1	L → V in sporadic cancers; somatic mutation.		VAR_044762
	Natural variant	138	1	A → D in sporadic cancers; somatic mutation.		VAR_044763
	Natural variant	138	1	A → P in LFS; germline mutation and in sporadic cancers; somatic mutation. Corresponds to variant rs28934875 [ dbSNP | Ensembl ].		VAR_005881
	Natural variant	138	1	A → S in LFS; germline mutation.		VAR_044764
	Natural variant	138	1	A → T in sporadic cancers; somatic mutation.		VAR_044765
	Natural variant	138	1	A → V in sporadic cancers; somatic mutation.		VAR_033034
	Natural variant	139	1	K → E in sporadic cancers; somatic mutation.		VAR_044766
	Natural variant	139	1	K → N in sporadic cancers; somatic mutation.		VAR_005882
	Natural variant	139	1	K → Q in sporadic cancers; somatic mutation.		VAR_044767
	Natural variant	139	1	K → R in sporadic cancers; somatic mutation.		VAR_044768
	Natural variant	139	1	K → T in sporadic cancers; somatic mutation.		VAR_044769
	Natural variant	140	1	T → A in sporadic cancers; somatic mutation.		VAR_044770
	Natural variant	140	1	T → I in sporadic cancers; somatic mutation.		VAR_044771
	Natural variant	140	1	T → N in a sporadic cancer; somatic mutation.		VAR_044772
	Natural variant	140	1	T → P in a sporadic cancer; somatic mutation.		VAR_044773
	Natural variant	140	1	T → S in sporadic cancers; somatic mutation.		VAR_044774
	Natural variant	141	1	C → A in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045793
	Natural variant	141	1	C → F in sporadic cancers; somatic mutation.		VAR_005885
	Natural variant	141	1	C → G in sporadic cancers; somatic mutation.		VAR_005884
	Natural variant	141	1	C → R in sporadic cancers; somatic mutation.		VAR_044775
	Natural variant	141	1	C → S in sporadic cancers; somatic mutation.		VAR_044776
	Natural variant	141	1	C → W in sporadic cancers; somatic mutation.		VAR_044777
	Natural variant	141	1	C → Y in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005886
	Natural variant	142	1	P → A in sporadic cancers; somatic mutation.		VAR_044778
	Natural variant	142	1	P → F in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions.		VAR_045794
	Natural variant	142	1	P → H in sporadic cancers; somatic mutation.		VAR_044779
	Natural variant	142	1	P → L in sporadic cancers; somatic mutation.		VAR_044780
	Natural variant	142	1	P → R in a sporadic cancer; somatic mutation.		VAR_044781
	Natural variant	142	1	P → S in sporadic cancers; somatic mutation.		VAR_044782
	Natural variant	142	1	P → T in sporadic cancers; somatic mutation.		VAR_044783
	Natural variant	143	1	V → A in sporadic cancers; somatic mutation; strong DNA binding ability at 32.5 degrees Celsius; strong reduction of transcriptional activity at 37.5 degrees Celsius.		VAR_005887
	Natural variant	143	1	V → E in sporadic cancers; somatic mutation.		VAR_044784
	Natural variant	143	1	V → G in sporadic cancers; somatic mutation.		VAR_044785
	Natural variant	143	1	V → L in sporadic cancers; somatic mutation.		VAR_044786
	Natural variant	143	1	V → M in sporadic cancers; somatic mutation.		VAR_044787
	Natural variant	144	1	Q → H in sporadic cancers; somatic mutation.		VAR_044788
	Natural variant	144	1	Q → K in sporadic cancers; somatic mutation.		VAR_044789
	Natural variant	144	1	Q → L in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044790
	Natural variant	144	1	Q → P in sporadic cancers; somatic mutation.		VAR_005888
	Natural variant	144	1	Q → R in sporadic cancers; somatic mutation.		VAR_044791
	Natural variant	145	1	L → M in sporadic cancers; somatic mutation.		VAR_044792
	Natural variant	145	1	L → P in sporadic cancers; somatic mutation.		VAR_005889
	Natural variant	145	1	L → Q in sporadic cancers; somatic mutation.		VAR_005890
	Natural variant	145	1	L → R in sporadic cancers; somatic mutation.		VAR_044793
	Natural variant	145	1	L → V in sporadic cancers; somatic mutation.		VAR_044794
	Natural variant	146	1	W → C in a sporadic cancer; somatic mutation.		VAR_044795
	Natural variant	146	1	W → G in sporadic cancers; somatic mutation.		VAR_044796
	Natural variant	146	1	W → L in sporadic cancers; somatic mutation.		VAR_044797
	Natural variant	146	1	W → R in sporadic cancers; somatic mutation.		VAR_044798
	Natural variant	146	1	W → S in sporadic cancers; somatic mutation.		VAR_044799
	Natural variant	147	1	V → A in sporadic cancers; somatic mutation.		VAR_044800
	Natural variant	147	1	V → D in sporadic cancers; somatic mutation.		VAR_005891
	Natural variant	147	1	V → E in sporadic cancers; somatic mutation.		VAR_044801
	Natural variant	147	1	V → F in a sporadic cancer; somatic mutation.		VAR_044802
	Natural variant	147	1	V → G in sporadic cancers; somatic mutation.		VAR_005892
	Natural variant	147	1	V → I in sporadic cancers; somatic mutation.		VAR_044803
	Natural variant	148	1	D → A in a sporadic cancer; somatic mutation.		VAR_044804
	Natural variant	148	1	D → E in sporadic cancers; somatic mutation.		VAR_044805
	Natural variant	148	1	D → G in a sporadic cancer; somatic mutation.		VAR_044806
	Natural variant	148	1	D → N in sporadic cancers; somatic mutation.		VAR_044807
	Natural variant	148	1	D → V in sporadic cancers; somatic mutation.		VAR_044808
	Natural variant	148	1	D → Y in sporadic cancers; somatic mutation.		VAR_044809
	Natural variant	149	1	S → F in sporadic cancers; somatic mutation.		VAR_044810
	Natural variant	149	1	S → P in sporadic cancers; somatic mutation.		VAR_005893
	Natural variant	149	1	S → T in sporadic cancers; somatic mutation.		VAR_044811
	Natural variant	150	1	T → A in a sporadic cancer; somatic mutation.		VAR_044812
	Natural variant	150	1	T → I in sporadic cancers; somatic mutation.		VAR_044813
	Natural variant	150	1	T → K in sporadic cancers; somatic mutation.		VAR_044814
	Natural variant	150	1	T → N in a sporadic cancer; somatic mutation.		VAR_044815
	Natural variant	150	1	T → P in a sporadic cancer; somatic mutation.		VAR_044816
	Natural variant	150	1	T → R in a sporadic cancer; somatic mutation.		VAR_044817
	Natural variant	151	1	P → A in sporadic cancers; somatic mutation.		VAR_005894
	Natural variant	151	1	P → H in sporadic cancers; somatic mutation.		VAR_044818
	Natural variant	151	1	P → L in sporadic cancers; somatic mutation.		VAR_044819
	Natural variant	151	1	P → R in sporadic cancers; somatic mutation.		VAR_044820
	Natural variant	151	1	P → S in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.164 Corresponds to variant rs28934874 [ dbSNP | Ensembl ].		VAR_005895
	Natural variant	151	1	P → T in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005896
	Natural variant	152	1	P → A in sporadic cancers; somatic mutation.		VAR_044821
	Natural variant	152	1	P → L in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.155		VAR_005897
	Natural variant	152	1	P → Q in sporadic cancers; somatic mutation.		VAR_044822
	Natural variant	152	1	P → R in sporadic cancers; somatic mutation.		VAR_044823
	Natural variant	152	1	P → S in sporadic cancers; somatic mutation.		VAR_005898
	Natural variant	152	1	P → T in sporadic cancers; somatic mutation.		VAR_044824
	Natural variant	153	1	P → A in sporadic cancers; somatic mutation.		VAR_044825
	Natural variant	153	1	P → F in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045795
	Natural variant	153	1	P → H in a sporadic cancer; somatic mutation.		VAR_044826
	Natural variant	153	1	P → L in sporadic cancers; somatic mutation.		VAR_044827
	Natural variant	153	1	P → R in a sporadic cancer; somatic mutation.		VAR_044828
	Natural variant	153	1	P → S in sporadic cancers; somatic mutation.		VAR_044829
	Natural variant	153	1	P → T in sporadic cancers; somatic mutation.		VAR_005899
	Natural variant	154	1	G → A in sporadic cancers; somatic mutation.		VAR_044830
	Natural variant	154	1	G → C in a sporadic cancer; somatic mutation.		VAR_044831
	Natural variant	154	1	G → D in sporadic cancers; somatic mutation.		VAR_044832
	Natural variant	154	1	G → I in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions.		VAR_045796
	Natural variant	154	1	G → S in sporadic cancers; somatic mutation.		VAR_044833
	Natural variant	154	1	G → V in a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation. Ref.153		VAR_005900
	Natural variant	155	1	T → A in sporadic cancers; somatic mutation.		VAR_005901
	Natural variant	155	1	T → I in sporadic cancers; somatic mutation.		VAR_044834
	Natural variant	155	1	T → M in a sporadic cancer; somatic mutation.		VAR_044835
	Natural variant	155	1	T → N in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044836
	Natural variant	155	1	T → P in sporadic cancers; somatic mutation; does not induce SNAI1 degradation.		VAR_044837
	Natural variant	155	1	T → S in sporadic cancers; somatic mutation.		VAR_044838
	Natural variant	156	1	R → C in sporadic cancers; somatic mutation.		VAR_044839
	Natural variant	156	1	R → G in sporadic cancers; somatic mutation.		VAR_044840
	Natural variant	156	1	R → H in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044841
	Natural variant	156	1	R → L in sporadic cancers; somatic mutation.		VAR_044842
	Natural variant	156	1	R → P in sporadic cancers; somatic mutation.		VAR_005902
	Natural variant	156	1	R → S in sporadic cancers; somatic mutation.		VAR_044843
	Natural variant	157	1	V → A in sporadic cancers; somatic mutation.		VAR_044844
	Natural variant	157	1	V → D in sporadic cancers; somatic mutation.		VAR_005903
	Natural variant	157	1	V → F in sporadic cancers; somatic mutation.		VAR_005904
	Natural variant	157	1	V → G in sporadic cancers; somatic mutation.		VAR_044845
	Natural variant	157	1	V → I in sporadic cancers; somatic mutation.		VAR_012977
	Natural variant	157	1	V → L in sporadic cancers; somatic mutation.		VAR_044846
	Natural variant	158	1	R → C in sporadic cancers; somatic mutation.		VAR_005905
	Natural variant	158	1	R → F in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045797
	Natural variant	158	1	R → G in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005906
	Natural variant	158	1	R → H in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005907
	Natural variant	158	1	R → L in sporadic cancers; somatic mutation.		VAR_044847
	Natural variant	158	1	R → P in sporadic cancers; somatic mutation.		VAR_044848
	Natural variant	158	1	R → Q in a sporadic cancer; somatic mutation.		VAR_044849
	Natural variant	158	1	R → S in sporadic cancers; somatic mutation.		VAR_044850
	Natural variant	158	1	R → Y in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045798
	Natural variant	159	1	A → D in sporadic cancers; somatic mutation.		VAR_044851
	Natural variant	159	1	A → F in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045799
	Natural variant	159	1	A → G in sporadic cancers; somatic mutation.		VAR_044852
	Natural variant	159	1	A → P in sporadic cancers; somatic mutation.		VAR_044853
	Natural variant	159	1	A → S in sporadic cancers; somatic mutation.		VAR_044854
	Natural variant	159	1	A → T in sporadic cancers; somatic mutation.		VAR_044855
	Natural variant	159	1	A → V in sporadic cancers; somatic mutation.		VAR_044856
	Natural variant	160 – 161	2	MA → IP in a sporadic cancer; somatic mutation.		VAR_047160
	Natural variant	160 – 161	2	MA → IS in sporadic cancers; somatic mutation.		VAR_047161
	Natural variant	160 – 161	2	MA → IT in a sporadic cancer; somatic mutation.		VAR_047162
	Natural variant	160	1	M → I in sporadic cancers; somatic mutation.		VAR_005908
	Natural variant	160	1	M → K in sporadic cancers; somatic mutation.		VAR_044857
	Natural variant	160	1	M → T in a sporadic cancer; somatic mutation.		VAR_044858
	Natural variant	160	1	M → V in sporadic cancers; somatic mutation.		VAR_044859
	Natural variant	161	1	A → D in sporadic cancers; somatic mutation.		VAR_044860
	Natural variant	161	1	A → F in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045800
	Natural variant	161	1	A → G in sporadic cancers; somatic mutation.		VAR_044861
	Natural variant	161	1	A → P in sporadic cancers; somatic mutation.		VAR_044862
	Natural variant	161	1	A → S in sporadic cancers; somatic mutation.		VAR_005909
	Natural variant	161	1	A → T in sporadic cancers; somatic mutation.		VAR_044863
	Natural variant	161	1	A → V in sporadic cancers; somatic mutation.		VAR_044864
	Natural variant	162	1	I → F in sporadic cancers; somatic mutation.		VAR_044865
	Natural variant	162	1	I → M in sporadic cancers; somatic mutation.		VAR_044866
	Natural variant	162	1	I → N in a breast cancer with no family history; germline mutation and in sporadic cancers; somatic mutation.		VAR_044867
	Natural variant	162	1	I → S in sporadic cancers; somatic mutation.		VAR_005910
	Natural variant	162	1	I → T in sporadic cancers; somatic mutation.		VAR_044868
	Natural variant	162	1	I → V in sporadic cancers; somatic mutation.		VAR_005911
	Natural variant	163	1	Y → C in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.181 Ref.182		VAR_033035
	Natural variant	163	1	Y → D in sporadic cancers; somatic mutation.		VAR_044869
	Natural variant	163	1	Y → F in a sporadic cancer; somatic mutation.		VAR_044870
	Natural variant	163	1	Y → H in sporadic cancers; somatic mutation.		VAR_005912
	Natural variant	163	1	Y → N in sporadic cancers; somatic mutation.		VAR_044871
	Natural variant	163	1	Y → S in sporadic cancers; somatic mutation.		VAR_044872
	Natural variant	164	1	K → E in sporadic cancers; somatic mutation.		VAR_044873
	Natural variant	164	1	K → M in sporadic cancers; somatic mutation.		VAR_044874
	Natural variant	164	1	K → N in sporadic cancers; somatic mutation.		VAR_005913
	Natural variant	164	1	K → Q in sporadic cancers; somatic mutation.		VAR_005914
	Natural variant	164	1	K → R in sporadic cancers; somatic mutation.		VAR_044875
	Natural variant	164	1	K → T in sporadic cancers; somatic mutation.		VAR_044876
	Natural variant	165	1	Q → E in sporadic cancers; somatic mutation.		VAR_044877
	Natural variant	165	1	Q → H in a sporadic cancer; somatic mutation.		VAR_044878
	Natural variant	165	1	Q → L in sporadic cancers; somatic mutation.		VAR_005915
	Natural variant	165	1	Q → P in sporadic cancers; somatic mutation.		VAR_044879
	Natural variant	165	1	Q → R in sporadic cancers; somatic mutation.		VAR_005916
	Natural variant	166	1	S → A in sporadic cancers; somatic mutation.		VAR_044880
	Natural variant	166	1	S → G in a sporadic cancer; somatic mutation.		VAR_044881
	Natural variant	166	1	S → L in sporadic cancers; somatic mutation.		VAR_005917
	Natural variant	166	1	S → P in sporadic cancers; somatic mutation.		VAR_044882
	Natural variant	166	1	S → T in sporadic cancers; somatic mutation.		VAR_044883
	Natural variant	167 – 168	2	QH → HD in a sporadic cancer; somatic mutation.		VAR_047163
	Natural variant	167 – 168	2	QH → YL in a sporadic cancer; somatic mutation.		VAR_047164
	Natural variant	167	1	Q → H in sporadic cancers; somatic mutation.		VAR_044884
	Natural variant	167	1	Q → K in LFS; germline mutation and in a sporadic cancer; somatic mutation.		VAR_044885
	Natural variant	167	1	Q → L in sporadic cancers; somatic mutation.		VAR_044886
	Natural variant	167	1	Q → R in sporadic cancers; somatic mutation.		VAR_044887
	Natural variant	168 – 169	2	HM → LI in a sporadic cancer; somatic mutation.		VAR_047165
	Natural variant	168	1	H → D in sporadic cancers; somatic mutation.		VAR_044888
	Natural variant	168	1	H → L in sporadic cancers; somatic mutation.		VAR_044889
	Natural variant	168	1	H → N in sporadic cancers; somatic mutation.		VAR_044890
	Natural variant	168	1	H → P in sporadic cancers; somatic mutation.		VAR_044891
	Natural variant	168	1	H → Q in sporadic cancers; somatic mutation.		VAR_044892
	Natural variant	168	1	H → R in sporadic cancers; somatic mutation.		VAR_005918
	Natural variant	168	1	H → V in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045801
	Natural variant	168	1	H → Y in sporadic cancers; somatic mutation.		VAR_044893
	Natural variant	169 – 170	2	MT → IS in a sporadic cancer; somatic mutation.		VAR_047166
	Natural variant	169	1	M → I in sporadic cancers; somatic mutation.		VAR_005919
	Natural variant	169	1	M → K in sporadic cancers; somatic mutation.		VAR_044894
	Natural variant	169	1	M → T in sporadic cancers; somatic mutation.		VAR_005920
	Natural variant	169	1	M → V in sporadic cancers; somatic mutation.		VAR_044895
	Natural variant	170	1	T → A in sporadic cancers; somatic mutation.		VAR_044896
	Natural variant	170	1	T → K in a sporadic cancer; somatic mutation.		VAR_044897
	Natural variant	170	1	T → M in sporadic cancers; somatic mutation.		VAR_005921
	Natural variant	170	1	T → P in a sporadic cancer; somatic mutation.		VAR_044898
	Natural variant	170	1	T → S in sporadic cancers; somatic mutation.		VAR_005922
	Natural variant	171	1	E → A in a sporadic cancer; somatic mutation.		VAR_044899
	Natural variant	171	1	E → D in sporadic cancers; somatic mutation.		VAR_044900
	Natural variant	171	1	E → G in sporadic cancers; somatic mutation.		VAR_044901
	Natural variant	171	1	E → K in sporadic cancers; somatic mutation.		VAR_044902
	Natural variant	171	1	E → Q in a sporadic cancer; somatic mutation.		VAR_044903
	Natural variant	171	1	E → V in sporadic cancers; somatic mutation.		VAR_044904
	Natural variant	172	1	V → A in sporadic cancers; somatic mutation.		VAR_005923
	Natural variant	172	1	V → D in sporadic cancers; somatic mutation.		VAR_044905
	Natural variant	172	1	V → F in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044906
	Natural variant	172	1	V → G in sporadic cancers; somatic mutation.		VAR_044907
	Natural variant	172	1	V → I in sporadic cancers; somatic mutation.		VAR_044908
	Natural variant	173	1	V → A in sporadic cancers; somatic mutation.		VAR_044909
	Natural variant	173	1	V → E in sporadic cancers; somatic mutation.		VAR_005924
	Natural variant	173	1	V → G in sporadic cancers; somatic mutation.		VAR_044910
	Natural variant	173	1	V → L in sporadic cancers; somatic mutation.		VAR_005925
	Natural variant	173	1	V → M in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005926
	Natural variant	173	1	V → W in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045802
	Natural variant	174	1	R → G in LFS; germline mutation and in a sporadic cancer; somatic mutation.		VAR_044911
	Natural variant	174	1	R → K in sporadic cancers; somatic mutation.		VAR_005927
	Natural variant	174	1	R → M in sporadic cancers; somatic mutation.		VAR_044912
	Natural variant	174	1	R → S in sporadic cancers; somatic mutation.		VAR_044913
	Natural variant	174	1	R → T in a sporadic cancer; somatic mutation.		VAR_044914
	Natural variant	174	1	R → W in sporadic cancers; somatic mutation.		VAR_044915
	Natural variant	175	1	R → C in sporadic cancers; somatic mutation.		VAR_005928
	Natural variant	175	1	R → G in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005929
	Natural variant	175	1	R → H in LFS; germline mutation and in sporadic cancers; somatic mutation; does not induce SNAI1 degradation. Ref.107 Ref.155 Ref.169 Ref.171 Ref.181 Corresponds to variant rs28934578 [ dbSNP | Ensembl ].		VAR_005932
	Natural variant	175	1	R → L in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005930
	Natural variant	175	1	R → P in sporadic cancers; somatic mutation.		VAR_005931
	Natural variant	175	1	R → Q in a sporadic cancer; somatic mutation.		VAR_044916
	Natural variant	175	1	R → S in sporadic cancers; somatic mutation.		VAR_044917
	Natural variant	176 – 177	2	CP → FS in a sporadic cancer; somatic mutation.		VAR_047167
	Natural variant	176	1	C → F in sporadic cancers; somatic mutation.		VAR_005933
	Natural variant	176	1	C → G in sporadic cancers; somatic mutation.		VAR_044918
	Natural variant	176	1	C → R in sporadic cancers; somatic mutation.		VAR_044919
	Natural variant	176	1	C → S in sporadic cancers; somatic mutation.		VAR_044920
	Natural variant	176	1	C → W in sporadic cancers; somatic mutation.		VAR_005934
	Natural variant	176	1	C → Y in sporadic cancers; somatic mutation.		VAR_044921
	Natural variant	177	1	P → A in a sporadic cancer; somatic mutation.		VAR_044922
	Natural variant	177	1	P → F in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions.		VAR_045803
	Natural variant	177	1	P → H in sporadic cancers; somatic mutation.		VAR_044923
	Natural variant	177	1	P → I in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045804
	Natural variant	177	1	P → L in sporadic cancers; somatic mutation.		VAR_005935
	Natural variant	177	1	P → R in sporadic cancers; somatic mutation.		VAR_036505
	Natural variant	177	1	P → S in sporadic cancers; somatic mutation.		VAR_044924
	Natural variant	177	1	P → T in a sporadic cancer; somatic mutation.		VAR_044925
	Natural variant	178 – 179	2	HH → QS in a sporadic cancer; somatic mutation.		VAR_047168
	Natural variant	178	1	H → D in sporadic cancers; somatic mutation.		VAR_044926
	Natural variant	178	1	H → HPHP in a Burkitt lymphoma. Ref.161		VAR_005936
	Natural variant	178	1	H → L in a sporadic cancer; somatic mutation.		VAR_044927
	Natural variant	178	1	H → N in sporadic cancers; somatic mutation.		VAR_044928
	Natural variant	178	1	H → P in sporadic cancers; somatic mutation.		VAR_044929
	Natural variant	178	1	H → Q in sporadic cancers; somatic mutation.		VAR_044930
	Natural variant	178	1	H → R in sporadic cancers; somatic mutation.		VAR_044931
	Natural variant	178	1	H → Y in sporadic cancers; somatic mutation.		VAR_044932
	Natural variant	179	1	H → D in sporadic cancers; somatic mutation.		VAR_044933
	Natural variant	179	1	H → L in sporadic cancers; somatic mutation.		VAR_044934
	Natural variant	179	1	H → N in sporadic cancers; somatic mutation.		VAR_044935
	Natural variant	179	1	H → P in sporadic cancers; somatic mutation.		VAR_044936
	Natural variant	179	1	H → Q in sporadic cancers; somatic mutation.		VAR_044937
	Natural variant	179	1	H → R in sporadic cancers; somatic mutation.		VAR_044938
	Natural variant	179	1	H → Y in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044939
	Natural variant	180	1	E → A in a sporadic cancer; somatic mutation.		VAR_044940
	Natural variant	180	1	E → D in sporadic cancers; somatic mutation.		VAR_044941
	Natural variant	180	1	E → G in a sporadic cancer; somatic mutation.		VAR_044942
	Natural variant	180	1	E → K in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044943
	Natural variant	180	1	E → Q in sporadic cancers; somatic mutation.		VAR_044944
	Natural variant	180	1	E → V in a sporadic cancer; somatic mutation.		VAR_044945
	Natural variant	181	1	R → C in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044946
	Natural variant	181	1	R → G in sporadic cancers; somatic mutation.		VAR_044947
	Natural variant	181	1	R → H in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044948
	Natural variant	181	1	R → L in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005937
	Natural variant	181	1	R → P in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044949
	Natural variant	181	1	R → S in sporadic cancers; somatic mutation.		VAR_044950
	Natural variant	182	1	C → R in sporadic cancers; somatic mutation.		VAR_044951
	Natural variant	182	1	C → S in sporadic cancers; somatic mutation.		VAR_005938
	Natural variant	182	1	C → Y in sporadic cancers; somatic mutation.		VAR_044952
	Natural variant	183	1	S → L in sporadic cancers; somatic mutation.		VAR_044953
	Natural variant	183	1	S → P in sporadic cancers; somatic mutation.		VAR_044954
	Natural variant	184	1	D → G in sporadic cancers; somatic mutation.		VAR_044955
	Natural variant	184	1	D → H in sporadic cancers; somatic mutation.		VAR_044956
	Natural variant	184	1	D → N in sporadic cancers; somatic mutation.		VAR_047169
	Natural variant	184	1	D → V in sporadic cancers; somatic mutation.		VAR_044957
	Natural variant	184	1	D → Y in sporadic cancers; somatic mutation.		VAR_005939
	Natural variant	185	1	S → C in a sporadic cancer; somatic mutation.		VAR_044958
	Natural variant	185	1	S → G in sporadic cancers; somatic mutation.		VAR_044959
	Natural variant	185	1	S → I in sporadic cancers; somatic mutation.		VAR_044960
	Natural variant	185	1	S → N in a sporadic cancer; somatic mutation.		VAR_044961
	Natural variant	185	1	S → R in sporadic cancers; somatic mutation.		VAR_044962
	Natural variant	185	1	S → T in a sporadic cancer; somatic mutation.		VAR_044963
	Natural variant	186	1	D → E in a sporadic cancer; somatic mutation.		VAR_044964
	Natural variant	186	1	D → G in sporadic cancers; somatic mutation.		VAR_044965
	Natural variant	186	1	D → H in sporadic cancers; somatic mutation.		VAR_044966
	Natural variant	186	1	D → N in sporadic cancers; somatic mutation.		VAR_044967
	Natural variant	186	1	D → V in sporadic cancers; somatic mutation.		VAR_044968
	Natural variant	186	1	D → Y in a sporadic cancer; somatic mutation.		VAR_005940
	Natural variant	187	1	G → C in sporadic cancers; somatic mutation.		VAR_005941
	Natural variant	187	1	G → D in sporadic cancers; somatic mutation.		VAR_044969
	Natural variant	187	1	G → N in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045805
	Natural variant	187	1	G → R in sporadic cancers; somatic mutation.		VAR_044970
	Natural variant	187	1	G → S in sporadic cancers; somatic mutation.		VAR_005942
	Natural variant	187	1	G → V in sporadic cancers; somatic mutation.		VAR_044971
	Natural variant	188	1	L → P in a sporadic cancer; somatic mutation.		VAR_044972
	Natural variant	188	1	L → V in sporadic cancers; somatic mutation.		VAR_044973
	Natural variant	189	1	A → D in a sporadic cancer; somatic mutation.		VAR_044974
	Natural variant	189	1	A → G in sporadic cancers; somatic mutation.		VAR_044975
	Natural variant	189	1	A → P in sporadic cancers; somatic mutation.		VAR_005943
	Natural variant	189	1	A → S in a sporadic cancer; somatic mutation.		VAR_044976
	Natural variant	189	1	A → T in sporadic cancers; somatic mutation.		VAR_044977
	Natural variant	189	1	A → V in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_044978
	Natural variant	190	1	P → A in sporadic cancers; somatic mutation.		VAR_044979
	Natural variant	190	1	P → H in a sporadic cancer; somatic mutation.		VAR_044980
	Natural variant	190	1	P → L in sporadic cancers; somatic mutation.		VAR_005944
	Natural variant	190	1	P → R in sporadic cancers; somatic mutation.		VAR_044981
	Natural variant	190	1	P → S in sporadic cancers; somatic mutation.		VAR_044982
	Natural variant	190	1	P → T in sporadic cancers; somatic mutation.		VAR_044983
	Natural variant	191	1	P → H in sporadic cancers; somatic mutation.		VAR_044984
	Natural variant	191	1	P → L in sporadic cancers; somatic mutation.		VAR_044985
	Natural variant	191	1	P → R in sporadic cancers; somatic mutation.		VAR_044986
	Natural variant	191	1	P → S in sporadic cancers; somatic mutation.		VAR_044987
	Natural variant	191	1	P → T in sporadic cancers; somatic mutation.		VAR_005945
	Natural variant	192 – 193	2	QH → HN in a sporadic cancer; somatic mutation.		VAR_047170
	Natural variant	192 – 193	2	QH → HY in a sporadic cancer; somatic mutation.		VAR_047171
	Natural variant	192	1	Q → H in sporadic cancers; somatic mutation.		VAR_044988
	Natural variant	192	1	Q → K in a sporadic cancer; somatic mutation.		VAR_044989
	Natural variant	192	1	Q → L in sporadic cancers; somatic mutation.		VAR_044990
	Natural variant	192	1	Q → P in sporadic cancers; somatic mutation.		VAR_044991
	Natural variant	192	1	Q → R in sporadic cancers; somatic mutation.		VAR_005946
	Natural variant	193	1	H → D in sporadic cancers; somatic mutation.		VAR_005947
	Natural variant	193	1	H → L in sporadic cancers; somatic mutation.		VAR_044992
	Natural variant	193	1	H → N in sporadic cancers; somatic mutation.		VAR_044993
	Natural variant	193	1	H → P in sporadic cancers; somatic mutation.		VAR_044994
	Natural variant	193	1	H → Q in sporadic cancers; somatic mutation.		VAR_044995
	Natural variant	193	1	H → R in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.169 Ref.181		VAR_005948
	Natural variant	193	1	H → Y in sporadic cancers; somatic mutation.		VAR_044996
	Natural variant	194	1	L → F in sporadic cancers; somatic mutation.		VAR_044997
	Natural variant	194	1	L → H in sporadic cancers; somatic mutation.		VAR_044998
	Natural variant	194	1	L → I in sporadic cancers; somatic mutation.		VAR_044999
	Natural variant	194	1	L → P in sporadic cancers; somatic mutation.		VAR_005949
	Natural variant	194	1	L → R in sporadic cancers; somatic mutation.		VAR_005950
	Natural variant	194	1	L → V in sporadic cancers; somatic mutation.		VAR_045000
	Natural variant	195	1	I → F in sporadic cancers; somatic mutation.		VAR_045001
	Natural variant	195	1	I → L in a sporadic cancer; somatic mutation.		VAR_047172
	Natural variant	195	1	I → N in sporadic cancers; somatic mutation.		VAR_045002
	Natural variant	195	1	I → S in sporadic cancers; somatic mutation.		VAR_045003
	Natural variant	195	1	I → T in sporadic cancers; somatic mutation.		VAR_005951
	Natural variant	195	1	I → V in a sporadic cancer; somatic mutation.		VAR_045004
	Natural variant	195	1	I → Y in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045806
	Natural variant	196	1	R → G in sporadic cancers; somatic mutation.		VAR_045005
	Natural variant	196	1	R → L in sporadic cancers; somatic mutation.		VAR_045006
	Natural variant	196	1	R → P in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045007
	Natural variant	196	1	R → Q in sporadic cancers; somatic mutation.		VAR_045008
	Natural variant	196	1	R → S in a sporadic cancer; somatic mutation.		VAR_045009
	Natural variant	197	1	V → E in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045010
	Natural variant	197	1	V → G in sporadic cancers; somatic mutation.		VAR_045011
	Natural variant	197	1	V → L in sporadic cancers; somatic mutation.		VAR_045012
	Natural variant	197	1	V → M in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045013
	Natural variant	198	1	E → D in a sporadic cancer; somatic mutation.		VAR_045014
	Natural variant	198	1	E → G in sporadic cancers; somatic mutation.		VAR_045015
	Natural variant	198	1	E → K in sporadic cancers; somatic mutation.		VAR_005952
	Natural variant	198	1	E → Q in sporadic cancers; somatic mutation.		VAR_045016
	Natural variant	198	1	E → V in a sporadic cancer; somatic mutation.		VAR_045017
	Natural variant	199	1	G → A in a sporadic cancer; somatic mutation.		VAR_045018
	Natural variant	199	1	G → E in sporadic cancers; somatic mutation.		VAR_045019
	Natural variant	199	1	G → R in sporadic cancers; somatic mutation.		VAR_045020
	Natural variant	199	1	G → V in sporadic cancers; somatic mutation.		VAR_045021
	Natural variant	200	1	N → D in sporadic cancers; somatic mutation.		VAR_045022
	Natural variant	200	1	N → I in sporadic cancers; somatic mutation.		VAR_045023
	Natural variant	200	1	N → K in a sporadic cancer; somatic mutation.		VAR_045024
	Natural variant	200	1	N → P in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045807
	Natural variant	200	1	N → S in sporadic cancers; somatic mutation.		VAR_045025
	Natural variant	200	1	N → T in a sporadic cancer; somatic mutation.		VAR_045026
	Natural variant	201 – 202	2	LR → FC in a sporadic cancer; somatic mutation.		VAR_047173
	Natural variant	201	1	L → F in sporadic cancers; somatic mutation.		VAR_045027
	Natural variant	201	1	L → P in a sporadic cancer; somatic mutation.		VAR_045028
	Natural variant	201	1	L → S in a sporadic cancer; somatic mutation.		VAR_045029
	Natural variant	202	1	R → C in sporadic cancers; somatic mutation.		VAR_045030
	Natural variant	202	1	R → G in sporadic cancers; somatic mutation.		VAR_045031
	Natural variant	202	1	R → H in sporadic cancers; somatic mutation.		VAR_045032
	Natural variant	202	1	R → L in sporadic cancers; somatic mutation.		VAR_045033
	Natural variant	202	1	R → P in sporadic cancers; somatic mutation.		VAR_045034
	Natural variant	202	1	R → S in sporadic cancers; somatic mutation.		VAR_045035
	Natural variant	203 – 204	2	VE → LV in a sporadic cancer; somatic mutation.		VAR_047174
	Natural variant	203	1	V → A in sporadic cancers; somatic mutation.		VAR_045036
	Natural variant	203	1	V → E in sporadic cancers; somatic mutation.		VAR_045037
	Natural variant	203	1	V → L in sporadic cancers; somatic mutation.		VAR_045038
	Natural variant	203	1	V → M in sporadic cancers; somatic mutation.		VAR_045039
	Natural variant	203	1	V → W in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045808
	Natural variant	204	1	E → A in sporadic cancers; somatic mutation.		VAR_045040
	Natural variant	204	1	E → D in sporadic cancers; somatic mutation.		VAR_045041
	Natural variant	204	1	E → G in sporadic cancers; somatic mutation.		VAR_045042
	Natural variant	204	1	E → K in sporadic cancers; somatic mutation.		VAR_045043
	Natural variant	204	1	E → Q in a sporadic cancer; somatic mutation.		VAR_045044
	Natural variant	204	1	E → V in a sporadic cancer; somatic mutation.		VAR_045045
	Natural variant	205	1	Y → C in sporadic cancers; somatic mutation.		VAR_005953
	Natural variant	205	1	Y → D in sporadic cancers; somatic mutation.		VAR_005954
	Natural variant	205	1	Y → F in sporadic cancers; somatic mutation.		VAR_047175
	Natural variant	205	1	Y → H in sporadic cancers; somatic mutation.		VAR_045046
	Natural variant	205	1	Y → N in sporadic cancers; somatic mutation.		VAR_045047
	Natural variant	205	1	Y → S in sporadic cancers; somatic mutation.		VAR_045048
	Natural variant	206	1	L → F in a sporadic cancer; somatic mutation.		VAR_045049
	Natural variant	206	1	L → M in a sporadic cancer; somatic mutation.		VAR_045050
	Natural variant	207 – 208	2	DD → EY in a sporadic cancer; somatic mutation.		VAR_047176
	Natural variant	207	1	D → E in sporadic cancers; somatic mutation.		VAR_045051
	Natural variant	207	1	D → G in sporadic cancers; somatic mutation.		VAR_045052
	Natural variant	207	1	D → H in sporadic cancers; somatic mutation.		VAR_045053
	Natural variant	207	1	D → N in sporadic cancers; somatic mutation.		VAR_045054
	Natural variant	207	1	D → V in a sporadic cancer; somatic mutation.		VAR_045055
	Natural variant	207	1	D → Y in a sporadic cancer; somatic mutation.		VAR_045056
	Natural variant	208	1	D → E in sporadic cancers; somatic mutation.		VAR_045057
	Natural variant	208	1	D → G in sporadic cancers; somatic mutation.		VAR_045058
	Natural variant	208	1	D → H in a sporadic cancer; somatic mutation.		VAR_045059
	Natural variant	208	1	D → I in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045809
	Natural variant	208	1	D → N in sporadic cancers; somatic mutation.		VAR_045060
	Natural variant	208	1	D → V in sporadic cancers; somatic mutation.		VAR_045061
	Natural variant	208	1	D → Y in a sporadic cancer; somatic mutation.		VAR_045062
	Natural variant	209	1	R → I in sporadic cancers; somatic mutation.		VAR_045063
	Natural variant	209	1	R → K in sporadic cancers; somatic mutation.		VAR_045064
	Natural variant	209	1	R → S in a sporadic cancer; somatic mutation.		VAR_045065
	Natural variant	209	1	R → T in sporadic cancers; somatic mutation.		VAR_045066
	Natural variant	210	1	N → D in sporadic cancers; somatic mutation.		VAR_045067
	Natural variant	210	1	N → H in sporadic cancers; somatic mutation.		VAR_045068
	Natural variant	210	1	N → I in a sporadic cancer; somatic mutation.		VAR_045069
	Natural variant	210	1	N → K in a sporadic cancer; somatic mutation.		VAR_045070
	Natural variant	210	1	N → S in sporadic cancers; somatic mutation.		VAR_045071
	Natural variant	210	1	N → T in a sporadic cancer; somatic mutation.		VAR_045072
	Natural variant	210	1	N → Y in a familial cancer not matching LFS; germline mutation.		VAR_045073
	Natural variant	211	1	T → A in sporadic cancers; somatic mutation.		VAR_045074
	Natural variant	211	1	T → I in sporadic cancers; somatic mutation.		VAR_045075
	Natural variant	211	1	T → N in sporadic cancers; somatic mutation.		VAR_045076
	Natural variant	211	1	T → P in a sporadic cancer; somatic mutation.		VAR_045077
	Natural variant	211	1	T → S in sporadic cancers; somatic mutation.		VAR_045078
	Natural variant	212	1	F → I in sporadic cancers; somatic mutation.		VAR_045079
	Natural variant	212	1	F → L in sporadic cancers; somatic mutation.		VAR_045080
	Natural variant	212	1	F → S in sporadic cancers; somatic mutation.		VAR_045081
	Natural variant	212	1	F → V in a sporadic cancer; somatic mutation.		VAR_045082
	Natural variant	212	1	F → Y in sporadic cancers; somatic mutation.		VAR_045083
	Natural variant	213	1	R → G in sporadic cancers; somatic mutation.		VAR_045084
	Natural variant	213	1	R → L in sporadic cancers; somatic mutation.		VAR_045085
	Natural variant	213	1	R → P in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.181		VAR_036506
	Natural variant	213	1	R → Q in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005955
	Natural variant	213	1	R → W in sporadic cancers; somatic mutation.		VAR_045086
	Natural variant	214	1	H → D in sporadic cancers; somatic mutation.		VAR_045087
	Natural variant	214	1	H → P in a sporadic cancer; somatic mutation.		VAR_045088
	Natural variant	214	1	H → Q in sporadic cancers; somatic mutation.		VAR_047177
	Natural variant	214	1	H → R in sporadic cancers; somatic mutation.		VAR_045089
	Natural variant	214	1	H → Y in sporadic cancers; somatic mutation.		VAR_045090
	Natural variant	215	1	S → C in sporadic cancers; somatic mutation.		VAR_045091
	Natural variant	215	1	S → G in sporadic cancers; somatic mutation.		VAR_045092
	Natural variant	215	1	S → I in sporadic cancers; somatic mutation.		VAR_045093
	Natural variant	215	1	S → K in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions.		VAR_045810
	Natural variant	215	1	S → N in sporadic cancers; somatic mutation.		VAR_045094
	Natural variant	215	1	S → R in sporadic cancers; somatic mutation.		VAR_045095
	Natural variant	215	1	S → T in sporadic cancers; somatic mutation.		VAR_045096
	Natural variant	216	1	V → A in sporadic cancers; somatic mutation.		VAR_045097
	Natural variant	216	1	V → E in sporadic cancers; somatic mutation.		VAR_045098
	Natural variant	216	1	V → G in sporadic cancers; somatic mutation.		VAR_045099
	Natural variant	216	1	V → L in sporadic cancers; somatic mutation.		VAR_045100
	Natural variant	216	1	V → M in sporadic cancers; somatic mutation.		VAR_005956
	Natural variant	216	1	V → W in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045811
	Natural variant	217	1	V → A in sporadic cancers; somatic mutation.		VAR_045101
	Natural variant	217	1	V → E in sporadic cancers; somatic mutation.		VAR_045102
	Natural variant	217	1	V → G in sporadic cancers; somatic mutation.		VAR_045103
	Natural variant	217	1	V → I in a sporadic cancer; somatic mutation.		VAR_045104
	Natural variant	217	1	V → L in sporadic cancers; somatic mutation.		VAR_045105
	Natural variant	217	1	V → M. Corresponds to variant rs35163653 [ dbSNP | Ensembl ].		VAR_047178
	Natural variant	218	1	V → A in sporadic cancers; somatic mutation.		VAR_045106
	Natural variant	218	1	V → E in sporadic cancers; somatic mutation.		VAR_045107
	Natural variant	218	1	V → G in sporadic cancers; somatic mutation.		VAR_045108
	Natural variant	218	1	V → L in sporadic cancers; somatic mutation.		VAR_045109
	Natural variant	218	1	V → M in sporadic cancers; somatic mutation.		VAR_045110
	Natural variant	219	1	P → C in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045812
	Natural variant	219	1	P → H in a sporadic cancer; somatic mutation.		VAR_045111
	Natural variant	219	1	P → L in sporadic cancers; somatic mutation.		VAR_045112
	Natural variant	219	1	P → R in a sporadic cancer; somatic mutation.		VAR_045113
	Natural variant	219	1	P → S in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045114
	Natural variant	219	1	P → T in sporadic cancers; somatic mutation.		VAR_045115
	Natural variant	220	1	Y → C in LFS; germline mutation and in sporadic cancers; somatic mutation. Ref.143 Ref.164 Ref.175		VAR_005957
	Natural variant	220	1	Y → D in sporadic cancers; somatic mutation.		VAR_045116
	Natural variant	220	1	Y → F in a sporadic cancer; somatic mutation.		VAR_045117
	Natural variant	220	1	Y → H in sporadic cancers; somatic mutation.		VAR_005958
	Natural variant	220	1	Y → N in sporadic cancers; somatic mutation.		VAR_045118
	Natural variant	220	1	Y → S in a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation.		VAR_005959
	Natural variant	221	1	E → A in sporadic cancers; somatic mutation.		VAR_045119
	Natural variant	221	1	E → D in sporadic cancers; somatic mutation.		VAR_045120
	Natural variant	221	1	E → G in sporadic cancers; somatic mutation.		VAR_045121
	Natural variant	221	1	E → K in sporadic cancers; somatic mutation.		VAR_045122
	Natural variant	221	1	E → Q in sporadic cancers; somatic mutation.		VAR_045123
	Natural variant	222	1	P → A in a sporadic cancer; somatic mutation.		VAR_045124
	Natural variant	222	1	P → L in sporadic cancers; somatic mutation.		VAR_045125
	Natural variant	222	1	P → Q in sporadic cancers; somatic mutation.		VAR_045126
	Natural variant	222	1	P → R in a sporadic cancer; somatic mutation.		VAR_045127
	Natural variant	222	1	P → S in sporadic cancers; somatic mutation.		VAR_045128
	Natural variant	222	1	P → T in sporadic cancers; somatic mutation.		VAR_045129
	Natural variant	223	1	P → A in a sporadic cancer; somatic mutation.		VAR_047179
	Natural variant	223	1	P → H in sporadic cancers; somatic mutation.		VAR_045130
	Natural variant	223	1	P → L in sporadic cancers; somatic mutation.		VAR_045131
	Natural variant	223	1	P → R in a sporadic cancer; somatic mutation.		VAR_045132
	Natural variant	223	1	P → S in a sporadic cancer; somatic mutation.		VAR_045133
	Natural variant	223	1	P → T in a sporadic cancer; somatic mutation.		VAR_045134
	Natural variant	224	1	E → D in sporadic cancers; somatic mutation.		VAR_045135
	Natural variant	224	1	E → G in sporadic cancers; somatic mutation.		VAR_045136
	Natural variant	224	1	E → K in sporadic cancers; somatic mutation.		VAR_045137
	Natural variant	224	1	E → V in a sporadic cancer; somatic mutation.		VAR_045138
	Natural variant	225	1	V → A in sporadic cancers; somatic mutation.		VAR_045139
	Natural variant	225	1	V → D in a sporadic cancer; somatic mutation.		VAR_045140
	Natural variant	225	1	V → F in sporadic cancers; somatic mutation.		VAR_045141
	Natural variant	225	1	V → G in a sporadic cancer; somatic mutation.		VAR_045142
	Natural variant	225	1	V → I in sporadic cancers; somatic mutation.		VAR_045143
	Natural variant	225	1	V → L in a sporadic cancer; somatic mutation.		VAR_045144
	Natural variant	226	1	G → A in sporadic cancers; somatic mutation.		VAR_045145
	Natural variant	226	1	G → D in sporadic cancers; somatic mutation.		VAR_047180
	Natural variant	226	1	G → N in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045844
	Natural variant	226	1	G → S in sporadic cancers; somatic mutation.		VAR_045146
	Natural variant	226	1	G → V in sporadic cancers; somatic mutation.		VAR_045147
	Natural variant	227	1	S → C in sporadic cancers; somatic mutation.		VAR_045148
	Natural variant	227	1	S → F in sporadic cancers; somatic mutation.		VAR_045149
	Natural variant	227	1	S → P in a sporadic cancer; somatic mutation.		VAR_045150
	Natural variant	227	1	S → T in LFS; germline mutation and in a sporadic cancer; somatic mutation.		VAR_045151
	Natural variant	228	1	D → A in sporadic cancers; somatic mutation.		VAR_045152
	Natural variant	228	1	D → E in sporadic cancers; somatic mutation.		VAR_005960
	Natural variant	228	1	D → G in sporadic cancers; somatic mutation.		VAR_045153
	Natural variant	228	1	D → H in sporadic cancers; somatic mutation.		VAR_045154
	Natural variant	228	1	D → N in sporadic cancers; somatic mutation.		VAR_045155
	Natural variant	228	1	D → P in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045845
	Natural variant	228	1	D → V in sporadic cancers; somatic mutation.		VAR_045156
	Natural variant	228	1	D → Y in sporadic cancers; somatic mutation.		VAR_045157
	Natural variant	229	1	C → G in a sporadic cancer; somatic mutation.		VAR_045158
	Natural variant	229	1	C → N in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045846
	Natural variant	229	1	C → R in sporadic cancers; somatic mutation.		VAR_045159
	Natural variant	229	1	C → S in sporadic cancers; somatic mutation.		VAR_045160
	Natural variant	229	1	C → Y in sporadic cancers; somatic mutation.		VAR_045161
	Natural variant	230	1	T → A in sporadic cancers; somatic mutation.		VAR_045162
	Natural variant	230	1	T → I in sporadic cancers; somatic mutation.		VAR_005961
	Natural variant	230	1	T → N in sporadic cancers; somatic mutation.		VAR_045163
	Natural variant	230	1	T → P in sporadic cancers; somatic mutation.		VAR_045164
	Natural variant	230	1	T → S in sporadic cancers; somatic mutation.		VAR_045165
	Natural variant	231	1	T → A in sporadic cancers; somatic mutation.		VAR_045166
	Natural variant	231	1	T → I in sporadic cancers; somatic mutation.		VAR_045167
	Natural variant	231	1	T → N in sporadic cancers; somatic mutation.		VAR_045168
	Natural variant	231	1	T → S in sporadic cancers; somatic mutation.		VAR_045169
	Natural variant	232	1	I → F in sporadic cancers; somatic mutation.		VAR_045170
	Natural variant	232	1	I → L in sporadic cancers; somatic mutation.		VAR_045171
	Natural variant	232	1	I → N in sporadic cancers; somatic mutation.		VAR_045172
	Natural variant	232	1	I → S in sporadic cancers; somatic mutation; does not induce SNAI1 degradation.		VAR_045173
	Natural variant	232	1	I → T in sporadic cancers; somatic mutation.		VAR_005962
	Natural variant	232	1	I → V in sporadic cancers; somatic mutation.		VAR_045174
	Natural variant	233	1	H → D in LFS; germline mutation and in a sporadic cancer; somatic mutation.		VAR_045175
	Natural variant	233	1	H → L in sporadic cancers; somatic mutation.		VAR_045176
	Natural variant	233	1	H → P in a sporadic cancer; somatic mutation.		VAR_045177
	Natural variant	233	1	H → Q in sporadic cancers; somatic mutation.		VAR_045178
	Natural variant	233	1	H → R in sporadic cancers; somatic mutation.		VAR_047181
	Natural variant	233	1	H → Y in sporadic cancers; somatic mutation.		VAR_045179
	Natural variant	234	1	Y → C in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005963
	Natural variant	234	1	Y → D in sporadic cancers; somatic mutation.		VAR_045180
	Natural variant	234	1	Y → F in a sporadic cancer; somatic mutation.		VAR_045181
	Natural variant	234	1	Y → H in sporadic cancers; somatic mutation.		VAR_005964
	Natural variant	234	1	Y → K in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045847
	Natural variant	234	1	Y → N in sporadic cancers; somatic mutation.		VAR_045182
	Natural variant	234	1	Y → Q in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045848
	Natural variant	234	1	Y → S in sporadic cancers; somatic mutation.		VAR_045183
	Natural variant	235	1	N → D in an adrenocortical carcinoma with no family history; germline mutation and in sporadic cancers; somatic mutation.		VAR_047182
	Natural variant	235	1	N → H in a sporadic cancer; somatic mutation.		VAR_045184
	Natural variant	235	1	N → I in sporadic cancers; somatic mutation.		VAR_045185
	Natural variant	235	1	N → M in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045849
	Natural variant	235	1	N → S in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045186
	Natural variant	235	1	N → T in sporadic cancers; somatic mutation.		VAR_045187
	Natural variant	235	1	N → Y in sporadic cancers; somatic mutation.		VAR_045188
	Natural variant	236	1	Y → C in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045189
	Natural variant	236	1	Y → D in sporadic cancers; somatic mutation.		VAR_045190
	Natural variant	236	1	Y → F in a sporadic cancer; somatic mutation.		VAR_045191
	Natural variant	236	1	Y → H in sporadic cancers; somatic mutation.		VAR_045192
	Natural variant	236	1	Y → N in sporadic cancers; somatic mutation.		VAR_045193
	Natural variant	236	1	Y → S in sporadic cancers; somatic mutation.		VAR_045194
	Natural variant	237	1	M → I in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005965
	Natural variant	237	1	M → K in sporadic cancers; somatic mutation.		VAR_045195
	Natural variant	237	1	M → L in sporadic cancers; somatic mutation.		VAR_045196
	Natural variant	237	1	M → R in sporadic cancers; somatic mutation.		VAR_045197
	Natural variant	237	1	M → T in sporadic cancers; somatic mutation.		VAR_045198
	Natural variant	237	1	M → V in sporadic cancers; somatic mutation.		VAR_045199
	Natural variant	238	1	C → F in sporadic cancers; somatic mutation.		VAR_005966
	Natural variant	238	1	C → G in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045200
	Natural variant	238	1	C → H in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions.		VAR_045850
	Natural variant	238	1	C → R in sporadic cancers; somatic mutation.		VAR_045201
	Natural variant	238	1	C → S in LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_045202
	Natural variant	238	1	C → W in sporadic cancers; somatic mutation.		VAR_045203
	Natural variant	238	1	C → Y in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation.		VAR_005967
	Natural variant	239	1	N → D in sporadic cancers; somatic mutation.		VAR_045204
	Natural variant	239	1	N → H in a sporadic cancer; somatic mutation.		VAR_045205
	Natural variant	239	1	N → I in a sporadic cancer; somatic mutation.		VAR_045206
	Natural variant	239	1	N → K in sporadic cancers; somatic mutation.		VAR_045207
	Natural variant	239	1	N → S in sporadic cancers; somatic mutation.		VAR_045208
	Natural variant	239	1	N → T in sporadic cancers; somatic mutation.		VAR_045209
	Natural variant	239	1	N → Y in sporadic cancers; somatic mutation.		VAR_045210
	Natural variant	240	1	S → C in sporadic cancers; somatic mutation.		VAR_045211
	Natural variant	240	1	S → G in sporadic cancers; somatic mutation.		VAR_045212
	Natural variant	240	1	S → I in sporadic cancers; somatic mutation.		VAR_005968
	Natural variant	240	1	S → N in sporadic cancers; somatic mutation.		VAR_045213
	Natural variant	240	1	S → P in a sporadic cancer; somatic mutation.		VAR_045214
	Natural variant	240	1	S → R in sporadic cancers; somatic mutation.		VAR_045215
	Natural variant	240	1	S → T in sporadic cancers; somatic mutation.